{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:24:21Z","timestamp":1793823861893,"version":"4.6.1"},"reference-count":522,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.survophthal.2021.05.007","type":"journal-article","created":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T21:47:34Z","timestamp":1621979254000},"page":"97-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Retinal toxicities of systemic anticancer drugs"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1992-0822","authenticated-orcid":false,"given":"Supriya","family":"Arora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thamolwan","family":"Surakiatchanukul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarun","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Helene","family":"Errera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitesh","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6817-2488","authenticated-orcid":false,"given":"Marco","family":"Lupidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3488-9680","authenticated-orcid":false,"given":"Jay","family":"Chhablani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0001","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/ICB.0000000000000368","article-title":"Pembrolizumab administration associated with posterior uveitis","volume":"11","author":"Aaberg","year":"2017","journal-title":"Retin Cases Brief Rep"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0002","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/14737140.2017.1296765","article-title":"Immune-related ocular toxicities in solid tumor patients treated with immune checkpoint inhibitors: a systematic review","volume":"17","author":"Abdel-Rahman","year":"2017","journal-title":"Expert Rev Anticancer Ther"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0003","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.5301\/ejo.5000724","article-title":"A case of bilateral uveitis and papillitis in a patient treated with pembrolizumab","volume":"26","author":"Abu Samra","year":"2016","journal-title":"Eur J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0004","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3181\/00379727-208-43849","article-title":"Effects of N-(4-hydroxyphenyl)retinamide on vitamin A metabolism in rats","volume":"208","author":"Adams","year":"1995","journal-title":"Proc Soc Exp Biol Med"},{"issue":"13","key":"10.1016\/j.survophthal.2021.05.007_bib0005","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1200\/JCO.2007.14.4956","article-title":"Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1\/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers","volume":"26","author":"Adjei","year":"2008","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.survophthal.2021.05.007_bib0006","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/(SICI)1097-0142(19961001)78:7<1359::AID-CNCR1>3.0.CO;2-G","article-title":"Ocular toxicity and cancer chemotherapy. A review","volume":"78","author":"al-Tweigeri","year":"1996","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0007","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/archopht.1967.00980030711004","article-title":"Ocular complications of vincristine therapy","volume":"78","author":"Albert","year":"1967","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0008","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/scientificamerican0160-99","article-title":"Radiation-imitating chemicals","volume":"202","author":"Alexander","year":"1960","journal-title":"Sci Am"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0009","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1177\/1078155218759805","article-title":"Cilioretinal artery occlusion associated with cisplatin","volume":"25","author":"Alkan","year":"2019","journal-title":"J Oncol Pharm Pract"},{"issue":"4642","key":"10.1016\/j.survophthal.2021.05.007_bib0010","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1126\/science.6701524","article-title":"Magnesium deficiency and hypertension: correlation between magnesium-deficient diets and microcirculatory changes in situ","volume":"223","author":"Altura","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0011","first-page":"95","article-title":"Necrotizing uveitis incident to perfusion of intractraial malignancies with nitrogen mustard or related compounds","volume":"58","author":"Anderson","year":"1960","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0012","first-page":"117","article-title":"Mammalian cones: disc shedding, phagocytosis, and renewal","volume":"17","author":"Anderson","year":"1978","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0013","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/CCO.0000000000000296","article-title":"Ocular and orbital side-effects of checkpoint inhibitors: a review article","volume":"28","author":"Antoun","year":"2016","journal-title":"Curr Opin Oncol"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0014","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00041327-200306000-00012","article-title":"Pathogenesis of nonarteritic anterior ischemic optic neuropathy","volume":"23","author":"Arnold","year":"2003","journal-title":"J Neuroophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0015","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.survophthal.2012.02.004","article-title":"Paraneoplastic vitelliform retinopathy: clinicopathologic correlation and review of the literature","volume":"57","author":"Aronow","year":"2012","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0016","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(13)70024-X","article-title":"MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study","volume":"14","author":"Ascierto","year":"2013","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0017","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/1097-0142(19880101)61:1<33::AID-CNCR2820610107>3.0.CO;2-I","article-title":"Reversible ocular toxicity related to tamoxifen therapy","volume":"61","author":"Ashford","year":"1988","journal-title":"Cancer"},{"issue":"25","key":"10.1016\/j.survophthal.2021.05.007_bib0018","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.1200\/JCO.2005.06.205","article-title":"Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4","volume":"23","author":"Attia","year":"2005","journal-title":"J Clin Oncol"},{"issue":"84","key":"10.1016\/j.survophthal.2021.05.007_bib0019","doi-asserted-by":"crossref","first-page":"84ra43","DOI":"10.1126\/scitranslmed.3002254","article-title":"A therapeutic antibody targeting BACE1 inhibits amyloid-\u03b2 production in vivo","volume":"3","author":"Atwal","year":"2011","journal-title":"Sci Transl Med"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0020","first-page":"693","article-title":"Characterization of the proximal estrogen-responsive element of human cathepsin D gene","volume":"8","author":"Augereau","year":"1994","journal-title":"Mol Endocrinol"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0021","first-page":"369","article-title":"Ocular effects of fenretinide, a vitamin A analog, in a chemoprevention trial of bladder cancer","volume":"24","author":"Baglietto","year":"2000","journal-title":"Cancer Detect Prev"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0022","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000323942","article-title":"Mixed vascular occlusion in a patient with interferon-associated retinopathy","volume":"2","author":"Bajaire","year":"2011","journal-title":"Case Rep Ophthalmol"},{"issue":"12","key":"10.1016\/j.survophthal.2021.05.007_bib0023","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s40265-013-0095-2","article-title":"Dabrafenib: first global approval","volume":"73","author":"Ballantyne","year":"2013","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0024","first-page":"19","article-title":"The reflexes of the fundus oculi: (Section of Ophthalmology)","volume":"34","author":"Ballantyne","year":"1940","journal-title":"Proc R Soc Med"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0025","first-page":"585","article-title":"Antisense knockdown of GLAST, a glial glutamate transporter, compromises retinal function","volume":"41","author":"Barnett","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0026","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1016\/j.jcjo.2015.09.008","article-title":"Posterior subcapsular cataracts and hypotony secondary to severe pembrolizumab induced uveitis: Case report","volume":"51","author":"Basilious","year":"2016","journal-title":"Can J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0027","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3129\/i11-001","article-title":"Abraxane-induced cystoid macular edema refractory to concomitant intravenous bevacizumab","volume":"46","author":"Baskin","year":"2011","journal-title":"Can J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0028","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00405506","article-title":"Peripheral neuropathy and ophthalmologic toxicity after treatment with cis-dichlorodiaminoplatinum II","volume":"96","author":"Becher","year":"1980","journal-title":"J Cancer Res Clin Oncol"},{"issue":"9-10","key":"10.1016\/j.survophthal.2021.05.007_bib0029","first-page":"1515","article-title":"Pharmacokinetics of non-protein-bound platinum species following administration of cis-dichlorodiammineplatinum(II)","volume":"63","author":"Belt","year":"1979","journal-title":"Cancer Treat Rep"},{"issue":"6825","key":"10.1016\/j.survophthal.2021.05.007_bib0030","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/bmj.304.6825.495","article-title":"Tamoxifen retinopathy: a rare but serious complication","volume":"304","author":"Bentley","year":"1992","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0031","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/WNO.0b013e3181d8e4af","article-title":"Pegylated interferon alpha-associated optic neuropathy","volume":"30","author":"Berg","year":"2010","journal-title":"J Neuroophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0032","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/1097-0142(19800215)45:4<764::AID-CNCR2820450425>3.0.CO;2-G","article-title":"Seizures and transient cortical blindness associated with cis-platinum (II) diamminedichloride (PDD) therapy in a thirty-year-old man","volume":"45","author":"Berman","year":"1980","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.survophthal.2021.05.007_bib0033","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1096\/fasebj.7.12.8375617","article-title":"Retinoids: in vitro interaction with retinol-binding protein and influence on plasma retinol","volume":"7","author":"Berni","year":"1993","journal-title":"Faseb j"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0034","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0014-5793(92)81046-O","article-title":"In vitro interaction of fenretinide with plasma retinol-binding protein and its functional consequences","volume":"308","author":"Berni","year":"1992","journal-title":"FEBS Lett"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0035","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00280-011-1692-y","article-title":"Montelukast attenuates side effects of cisplatin including testicular, spermatological, and hormonal damage in male rats","volume":"69","author":"Beytur","year":"2012","journal-title":"Cancer Chemother Pharmacol"},{"issue":"8","key":"10.1016\/j.survophthal.2021.05.007_bib0036","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1097\/IAE.0b013e3181d20589","article-title":"Rapid vision loss associated with fludarabine administration","volume":"30","author":"Bishop","year":"2010","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0037","first-page":"1599","article-title":"Imatinib induces apoptosis by inhibiting PDGF- but not insulin-induced PI 3-kinase\/Akt survival signaling in RGC-5 retinal ganglion cells","volume":"15","author":"Biswas","year":"2009","journal-title":"Mol Vis"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0038","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/0002-9394(77)90904-7","article-title":"Oculomotor disturbances associated with 5-fluorouracil chemotherapy","volume":"83","author":"Bixenman","year":"1977","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0039","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00280-011-1620-1","article-title":"Pilot study of PD-0325901 in previously treated patients with advanced melanoma, breast cancer, and colon cancer","volume":"68","author":"Boasberg","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"issue":"13","key":"10.1016\/j.survophthal.2021.05.007_bib0040","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1158\/0008-5472.CAN-10-0118","article-title":"Selective BRAFV600E inhibition enhances T-cell recognition of melanoma without affecting lymphocyte function","volume":"70","author":"Boni","year":"2010","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0041","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/1097-0142(19900201)65:3<452::AID-CNCR2820650313>3.0.CO;2-8","article-title":"Early blindness and coma during intrathecal chemotherapy for meningeal carcinomatosis","volume":"65","author":"Boogerd","year":"1990","journal-title":"Cancer"},{"issue":"1 Suppl 1","key":"10.1016\/j.survophthal.2021.05.007_bib0042","first-page":"3","article-title":"A perspective on the clinical effectiveness and tolerance of interferon-alpha","volume":"25","author":"Borden","year":"1998","journal-title":"Semin Oncol"},{"issue":"11","key":"10.1016\/j.survophthal.2021.05.007_bib0043","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1200\/JCO.1986.4.11.1684","article-title":"Increased plasma renin and aldosterone in patients treated with cisplatin-based chemotherapy for metastatic germ-cell tumors","volume":"4","author":"Bosl","year":"1986","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0044","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/08820530701418524","article-title":"Intravitreous vascular endothelial growth factor (VEGF) inhibitor therapy for tamoxifen induced macular edema","volume":"22","author":"Bourla","year":"2007","journal-title":"Semin Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0045","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ajo.2007.03.023","article-title":"Peripheral retinopathy and maculopathy in high-dose tamoxifen therapy","volume":"144","author":"Bourla","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.007_bib0046","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jamaophthalmol.2013.692","article-title":"Effect of intravitreous anti-vascular endothelial growth factor therapy on choroidal thickness in neovascular age-related macular degeneration using spectral-domain optical coherence tomography","volume":"131","author":"Branchini","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0047","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.preteyeres.2006.05.003","article-title":"Muller cells in the healthy and diseased retina","volume":"25","author":"Bringmann","year":"2006","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0048","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01203288","article-title":"Punctal and canalicular stenosis associated with systemic fluorouracil therapy. Report of five cases and review of the literature","volume":"90","author":"Brink","year":"1995","journal-title":"Doc Ophthalmol"},{"issue":"12","key":"10.1016\/j.survophthal.2021.05.007_bib0049","article-title":"Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome","volume":"12","author":"Brown","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0050","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002249.pub4","article-title":"Clomiphene and anti-oestrogens for ovulation induction in PCOS","author":"Brown","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"52","key":"10.1016\/j.survophthal.2021.05.007_bib0051","doi-asserted-by":"crossref","first-page":"7584","DOI":"10.1038\/sj.onc.1203200","article-title":"Both FGF1 and bcl-x synthesis are necessary for the reduction of apoptosis in retinal pigmented epithelial cells by FGF2: role of the extracellular signal-regulated kinase 2","volume":"18","author":"Bryckaert","year":"1999","journal-title":"Oncogene"},{"issue":"42","key":"10.1016\/j.survophthal.2021.05.007_bib0052","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1038\/sj.onc.1203872","article-title":"Regulation of proliferation-survival decisions is controlled by FGF1 secretion in retinal pigmented epithelial cells","volume":"19","author":"Bryckaert","year":"2000","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0053","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1200\/JCO.2010.29.5865","article-title":"Phase II study of the antibody drug conjugate trastuzumab-DM1 for the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer after prior HER2-directed therapy","volume":"29","author":"Burris","year":"2011","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0054","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/1097-0142(19810101)47:1<37::AID-CNCR2820470108>3.0.CO;2-8","article-title":"Transient cortical blindness secondary to vincristine therapy in childhood malignancies","volume":"47","author":"Byrd","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0055","article-title":"Progressive choroidal thinning (leptochoroid) and fundus depigmentation associated with checkpoint inhibitors","volume":"19","author":"Canestraro","year":"2020","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"14","key":"10.1016\/j.survophthal.2021.05.007_bib0056","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/jnci\/86.14.1099","article-title":"Optic nerve disturbances: A new form of paclitaxel neurotoxicity","volume":"86","author":"Capri","year":"1994","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0057","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1600-0404.1997.tb00280.x","article-title":"Recovering optic neuritis during systemic cisplatin and carboplatin chemotherapy","volume":"96","author":"Caraceni","year":"1997","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0058","first-page":"34","article-title":"Cisplatinum retinopathy","volume":"26","author":"Caruso R","year":"1985","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0059","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1001\/archopht.116.6.759","article-title":"Effects of fenretinide (4-HPR) on dark adaptation","volume":"116","author":"Caruso","year":"1998","journal-title":"Arch Ophthalmol"},{"issue":"23","key":"10.1016\/j.survophthal.2021.05.007_bib0060","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1001\/jama.2014.6096","article-title":"Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: A randomized clinical trial","volume":"311","author":"Carvajal","year":"2014","journal-title":"Jama"},{"issue":"8","key":"10.1016\/j.survophthal.2021.05.007_bib0061","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1080\/13543784.2017.1351543","article-title":"Selumetinib for the treatment of non-small cell lung cancer","volume":"26","author":"Casaluce","year":"2017","journal-title":"Expert Opin Investig Drugs"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0062","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrc1529","article-title":"Timeline: Chemotherapy and the war on cancer","volume":"5","author":"Chabner","year":"2005","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"10.1016\/j.survophthal.2021.05.007_bib0063","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1634\/theoncologist.2018-0296","article-title":"Adverse event management in patients with BRAF V600E-mutant non-small cell lung cancer treated with dabrafenib plus trametinib","volume":"24","author":"Chalmers","year":"2019","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0064","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0161-6420(94)31349-2","article-title":"The treatment of choroidal neovascular membranes by alpha interferon. An efficacy and toxicity study","volume":"101","author":"Chan","year":"1994","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0065","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/pcmr.12607","article-title":"A major responder to ipilimumab and nivolumab in metastatic uveal melanoma with concomitant autoimmunity","volume":"30","author":"Chan","year":"2017","journal-title":"Pigment Cell Melanoma Res"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0066","first-page":"148","article-title":"Low-dose tamoxifen retinopathy","volume":"27","author":"Chang","year":"1992","journal-title":"Can J Ophthalmol"},{"issue":"26","key":"10.1016\/j.survophthal.2021.05.007_bib0067","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0068","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1046\/j.1365-2141.2000.02206.x","article-title":"Sight-threatening varicella zoster virus infection after fludarabine treatment","volume":"110","author":"Chee","year":"2000","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0069","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1159\/000055565","article-title":"In vitro testing of antioxidants and biochemical end-points in bovine retinal tissue","volume":"31","author":"Chida","year":"1999","journal-title":"Ophthalmic Res"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2014.07.003","article-title":"Ocular toxicity in BRAF mutant cutaneous melanoma patients treated with vemurafenib","volume":"158","author":"Choe","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0071","first-page":"616","article-title":"[Interferon-induced retinal changes]","volume":"98","author":"Chuman","year":"1994","journal-title":"Nippon Ganka Gakkai Zasshi"},{"issue":"10","key":"10.1016\/j.survophthal.2021.05.007_bib0072","first-page":"1225","article-title":"Central nervous system toxicity of fludarabine phosphate","volume":"70","author":"Chun","year":"1986","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0073","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3928\/15428877-20100215-06","article-title":"Early detection of tamoxifen-induced maculopathy in patients with low cumulative doses of tamoxifen","author":"Chung","year":"2010","journal-title":"Ophthalmic Surg Lasers Imaging"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.007_bib0074","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3341\/kjo.2010.24.5.306","article-title":"Estrogen antagonist and development of macular hole","volume":"24","author":"Chung","year":"2010","journal-title":"Korean J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0075","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/toxsci\/kfp131","article-title":"Hemangiosarcoma in rodents: Mode-of-action evaluation and human relevance","volume":"111","author":"Cohen","year":"2009","journal-title":"Toxicol Sci"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.007_bib0076","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0277-5379(89)90124-7","article-title":"Tolerability of the synthetic retinoid Fenretinide (HPR)","volume":"25","author":"Costa","year":"1989","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0077","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3928\/23258160-20150610-10","article-title":"Ipilimumab-associated retinopathy","volume":"46","author":"Crews","year":"2015","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0078","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/IAE.0000000000002533","article-title":"Tamoxifen-induced chorioretinal changes: An optical coherence tomography and optical coherence tomography angiography study","volume":"40","author":"Crisostomo","year":"2020","journal-title":"Retina"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0079","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10792-005-5424-3","article-title":"Tamoxifen therapy conveys increased risk of developing a macular hole","volume":"26","author":"Cronin","year":"2005","journal-title":"Int Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0080","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/CJI.0000000000000066","article-title":"Vogt-Koyanagi-Harada-like syndrome after CTLA-4 inhibition with ipilimumab for metastatic melanoma","volume":"38","author":"Crosson","year":"2015","journal-title":"J Immunother"},{"issue":"12","key":"10.1016\/j.survophthal.2021.05.007_bib0081","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1136\/bjo.2004.043968","article-title":"Is screening for interferon retinopathy in hepatitis C justified?","volume":"88","author":"Cuthbertson","year":"2004","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0082","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jhep.2005.07.026","article-title":"Ophthalmologic side effects during alpha-interferon therapy for viral hepatitis","volume":"44","author":"d'Alteroche","year":"2006","journal-title":"J Hepatol"},{"issue":"1-2","key":"10.1016\/j.survophthal.2021.05.007_bib0083","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/08820538.2015.1114849","article-title":"New translational research in the medical management of orbital melanoma","volume":"31","author":"Dagi Glass","year":"2016","journal-title":"Semin Ophthalmol"},{"issue":"15","key":"10.1016\/j.survophthal.2021.05.007_bib0084","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJMc1108651","article-title":"Vemurafenib in melanoma with BRAF V600E mutation","volume":"365","author":"Dalle","year":"2011","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0085","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/IAE.0000000000002181","article-title":"Checkpoint inhibitor immune therapy: Systemic indications and ophthalmic side effects","volume":"38","author":"Dalvin","year":"2018","journal-title":"Retina"},{"issue":"10","key":"10.1016\/j.survophthal.2021.05.007_bib0086","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1002\/1097-0142(20011115)92:10<2592::AID-CNCR1612>3.0.CO;2-4","volume":"92","author":"Damascelli","year":"2001","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0087","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1167\/iovs.18-25346","article-title":"Rabbit model of intra-arterial chemotherapy toxicity demonstrates retinopathy and vasculopathy related to drug and dose, not procedure or approach","volume":"60","author":"Daniels","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0088","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: Molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur J Pharmacol"},{"issue":"9869","key":"10.1016\/j.survophthal.2021.05.007_bib0089","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0140-6736(12)61963-1","article-title":"Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial","volume":"381","author":"Davies","year":"2013","journal-title":"Lancet"},{"issue":"6892","key":"10.1016\/j.survophthal.2021.05.007_bib0090","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0091","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2147\/ITT.S141577","article-title":"Safety of checkpoint inhibitors for cancer treatment: strategies for patient monitoring and management of immune-mediated adverse events","volume":"6","author":"Davies","year":"2017","journal-title":"Immunotargets Ther"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0092","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.soncn.2017.08.003","article-title":"Cancer therapy with checkpoint inhibitors: Establishing a role for ophthalmology","volume":"33","author":"Davis","year":"2017","journal-title":"Semin Oncol Nurs"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0093","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.autrev.2015.12.001","article-title":"The autoimmune diseases of the eyes","volume":"15","author":"de Andrade","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0094","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/art.39406","article-title":"Autoimmune arthropathy and uveitis as complications of programmed death 1 inhibitor treatment","volume":"68","author":"de Velasco","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0095","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0959-8049(96)00351-6","article-title":"Long-term effects of fenretinide on retinal function","volume":"33","author":"Decensi","year":"1997","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0096","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/jnci\/86.2.105","article-title":"Effect of the synthetic retinoid fenretinide on dark adaptation and the ocular surface","volume":"86","author":"Decensi","year":"1994","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"10.1016\/j.survophthal.2021.05.007_bib0097","first-page":"1441","article-title":"Ultrafiltrate and total platinum in plasma and cerebrospinal fluid in a patient with neuroblastoma","volume":"69","author":"DeGregorio","year":"1985","journal-title":"Cancer Treat Rep"},{"issue":"10","key":"10.1016\/j.survophthal.2021.05.007_bib0098","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1097\/OPX.0b013e318269111d","article-title":"Imatinib mesylate (Gleevec) induced unilateral optic disc edema","volume":"89","author":"DeLuca","year":"2012","journal-title":"Optom Vis Sci"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0099","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0190-9622(86)80475-3","article-title":"Abnormal night vision and altered dark adaptometry in patients treated with isotretinoin for acne","volume":"14","author":"Denman","year":"1986","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0100","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1471-4159.2000.0750151.x","article-title":"Endogenous and exogenous fibroblast growth factor 2 support survival of chick retinal neurons by control of neuronal neuronal bcl-x(L) and bcl-2 expression through a fibroblast berowth factor receptor 1- and ERK-dependent pathway","volume":"75","author":"D\u00e9sir\u00e9","year":"2000","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0101","first-page":"33","article-title":"Report of vascilitis and blindness after intracarotid injection of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in dogs","volume":"57","author":"DeWys","year":"1973","journal-title":"Cancer Chemother Rep"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.007_bib0102","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1053\/j.seminoncol.2010.09.007","article-title":"The emerging toxicity profiles of anti-CTLA-4 antibodies across clinical indications","volume":"37","author":"Di Giacomo","year":"2010","journal-title":"Semin Oncol"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0103","first-page":"84s","article-title":"Cerebral blindness in association with cis-platinum chemotherapy for advanced carcinoma of the fallopian tube","volume":"59","author":"Diamond","year":"1982","journal-title":"Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.survophthal.2021.05.007_bib0104","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/CJI.0000000000000143","article-title":"Pembrolizumab-triggered uveitis: An additional surrogate marker for responders in melanoma immunotherapy?","volume":"39","author":"Diem","year":"2016","journal-title":"J Immunother"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0105","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/ajcn\/51.6.1082","article-title":"Alteration of retinol-binding-protein concentrations by the synthetic retinoid fenretinide in healthy human subjects","volume":"51","author":"Dimitrov","year":"1990","journal-title":"Am J Clin Nutr"},{"issue":"9","key":"10.1016\/j.survophthal.2021.05.007_bib0106","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1002\/j.1460-2075.1990.tb07454.x","article-title":"Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors","volume":"9","author":"Dionne","year":"1990","journal-title":"EMBO J"},{"issue":"9","key":"10.1016\/j.survophthal.2021.05.007_bib0107","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1200\/JCO.1986.4.9.1405","article-title":"Vascular toxicity associated with antineoplastic agents","volume":"4","author":"Doll","year":"1986","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.survophthal.2021.05.007_bib0108","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1002\/1097-0142(19811115)48:10<2158::AID-CNCR2820481007>3.0.CO;2-I","article-title":"Ocular irritation from high-dose methotrexate therapy: pharmacokinetics of drug in the tear film","volume":"48","author":"Doroshow","year":"1981","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0109","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.ajo.2014.02.046","article-title":"Pseudocystic foveal cavitation in tamoxifen retinopathy","volume":"157","author":"Doshi","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"22 Pt 1","key":"10.1016\/j.survophthal.2021.05.007_bib0110","doi-asserted-by":"crossref","first-page":"6681","DOI":"10.1158\/1078-0432.CCR-07-0187","article-title":"Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade","volume":"13","author":"Downey","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0111","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12348-015-0049-9","article-title":"Severe bilateral panuveitis during melanoma treatment by Dabrafenib and Trametinib","volume":"5","author":"Draganova","year":"2015","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0112","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/0014-4800(78)90010-2","article-title":"Drug-induced retinal lipidosis: Differential susceptibilities of pigment epithelium and neuroretina toward several amphiphilic cationic drugs","volume":"28","author":"Drenckhahn","year":"1978","journal-title":"Exp Mol Pathol"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.007_bib0113","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/annonc\/mdx040","article-title":"Incidence, course, and management of toxicities associated with cobimetinib in combination with vemurafenib in the coBRIM study","volume":"28","author":"Dr\u00e9no","year":"2017","journal-title":"Ann Oncol"},{"issue":"23","key":"10.1016\/j.survophthal.2021.05.007_bib0114","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","article-title":"Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia","volume":"355","author":"Druker","year":"2006","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0115","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/09273948.2017.1373827","article-title":"Induction of Vogt-Koyanagi-Harada disease by interferon-alpha and ribavirin treatment in patients with hepatitis C: A case report and review of the literature","volume":"27","author":"Duan","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"issue":"10","key":"10.1016\/j.survophthal.2021.05.007_bib0116","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1200\/JCO.2005.00.240","article-title":"Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma","volume":"23","author":"Dudley","year":"2005","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.survophthal.2021.05.007_bib0117","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00432-017-2384-8","article-title":"Retinal toxicity after cisplatin-based chemotherapy in patients with germ cell cancer","volume":"143","author":"Dulz","year":"2017","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0118","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/CCO.0b013e32834fca92","article-title":"Resistance patterns with tyrosine kinase inhibitors in melanoma: New insights","volume":"24","author":"Dummer","year":"2012","journal-title":"Curr Opin Oncol"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0119","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1470-2045(17)30180-8","article-title":"Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): A multicentre, open-label, randomized, phase 3 trial","volume":"18","author":"Dummer","year":"2017","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.survophthal.2021.05.007_bib0120","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/eye.2015.82","article-title":"MEK inhibitors: A new class of chemotherapeutic agents with ocular toxicity","volume":"29","author":"Duncan","year":"2015","journal-title":"Eye (Lond)"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0121","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/ICB.0000000000000433","article-title":"Possible efficacy of topical dorzolamide in the treatment of paclitaxel-related cystoid macular edema.","volume":"12","author":"Dwivedi","year":"2018","journal-title":"Retin Cases Brief Rep"},{"issue":"11","key":"10.1016\/j.survophthal.2021.05.007_bib0122","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1001\/archophthalmol.2011.223","article-title":"Histopathologic observations after intra-arterial chemotherapy for retinoblastoma","volume":"129","author":"Eagle","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0123","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/eye.2012.228","article-title":"Topical dorzolamide therapy for taxane-related macular oedema","volume":"27","author":"Ehlers","year":"2013","journal-title":"Eye (Lond)"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0124","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/0003-4819-87-3-293","article-title":"Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer","volume":"87","author":"Einhorn","year":"1977","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0125","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/bjo.88.1.125","article-title":"Short wavelength automated perimetry and tamoxifen use","volume":"88","author":"Eisner","year":"2004","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.007_bib0126","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/OPX.0b013e31816bea3b","article-title":"Retinal hemorrhages in anastrozole users","volume":"85","author":"Eisner","year":"2008","journal-title":"Optom Vis Sci"},{"issue":"11","key":"10.1016\/j.survophthal.2021.05.007_bib0127","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.visres.2005.11.003","article-title":"The color appearance of stimuli detected via short-wavelength-sensitive cones for breast cancer survivors using tamoxifen","volume":"46","author":"Eisner","year":"2006","journal-title":"Vision Res"},{"issue":"10","key":"10.1016\/j.survophthal.2021.05.007_bib0128","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3109\/02713683.2011.594202","article-title":"Breast cancer medications and vision: Effects of treatments for early-stage disease","volume":"36","author":"Eisner","year":"2011","journal-title":"Curr Eye Res"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0129","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10549-008-0156-5","article-title":"Vitreo-retinal traction and anastrozole use","volume":"117","author":"Eisner","year":"2009","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0130","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0940-9602(11)80384-5","article-title":"Localization of lysosomal enzymes in the retina and retinal pigment epithelium of RCS rats","volume":"176","author":"el-Hifnawi","year":"1994","journal-title":"Ann Anat"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0131","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1034\/j.1600-0773.2002.910103.x","article-title":"Tamoxifen induces changes in the lipid composition of the retinal pigment epithelium cell line D407","volume":"91","author":"Engelke","year":"2002","journal-title":"Pharmacol Toxicol"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.007_bib0132","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0161-6420(01)00546-2","article-title":"Interferon-induced retinopathy in asymptomatic cancer patients","volume":"108","author":"Esmaeli","year":"2001","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0133","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/cncr.10729","article-title":"Severe periorbital edema secondary to STI571 (Gleevec)","volume":"95","author":"Esmaeli","year":"2002","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.007_bib0134","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/1097-0142(19840901)54:5<794::AID-CNCR2820540503>3.0.CO;2-F","article-title":"Intracarotid infusion of cis-diamminedichloroplatinum in the treatment of recurrent malignant brain tumors","volume":"54","author":"Feun","year":"1984","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0135","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1055\/s-0042-102668","article-title":"Intraocular Inflammation associated with new therapies for cutaneous melanoma - case series and review","volume":"233","author":"Fierz","year":"2016","journal-title":"Klin Monbl Augenheilkd"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0136","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/15569527.2018.1518330","article-title":"The protective effects of astaxanthin against cisplatin-induced retinal toxicity","volume":"38","author":"F\u0131nd\u0131k","year":"2019","journal-title":"Cutan Ocul Toxicol"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0137","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/0002-9394(81)90638-3","article-title":"Macular edema and cystoid macular edema","volume":"92","author":"Fine","year":"1981","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0138","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000212087","article-title":"Carboplatin-induced bilateral papilledema: A case report","volume":"2","author":"Fischer","year":"2009","journal-title":"Case Rep Oncol"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0139","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0002-9394(76)90544-4","article-title":"Optic atrophy following prophylactic chemotherapy and cranial radiation for acute lymphocytic leukemia","volume":"82","author":"Fishman","year":"1976","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0140","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1203421","article-title":"Improved survival with MEK inhibition in BRAF-mutated melanoma","volume":"367","author":"Flaherty","year":"2012","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0141","first-page":"349","article-title":"Intraarterial infusion of carboplatin in the treatment of malignant gliomas: A phase II study","volume":"36","author":"Foll\u00e9zou","year":"1989","journal-title":"Neoplasma"},{"issue":"21","key":"10.1016\/j.survophthal.2021.05.007_bib0142","first-page":"6149","article-title":"Plasma retinol level reduction by the synthetic retinoid fenretinide: A one year follow-up study of breast cancer patients","volume":"49","author":"Formelli","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0143","first-page":"843","article-title":"N-(4-Hydroxyphenyl)retinamide (bHPR) lowers plasma retinol levels in rats","volume":"15","author":"Formelli F","year":"1987","journal-title":"Med Sci Res"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0144","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/j.ijid.2011.09.022","article-title":"Incidence and risk factors of retinopathy in Egyptian patients with chronic hepatitis C virus treated with pegylated interferon plus ribavirin","volume":"16","author":"Fouad","year":"2012","journal-title":"Int J Infect Dis"},{"issue":"12","key":"10.1016\/j.survophthal.2021.05.007_bib0145","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/j.ophtha.2017.05.038","article-title":"Clinical and morphologic characteristics of MEK inhibitor-associated retinopathy: Differences from central serous chorioretinopathy","volume":"124","author":"Francis","year":"2017","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0146","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ophtha.2010.03.063","article-title":"Interferon alfa-associated anterior ischemic optic neuropathy","volume":"118","author":"Fraunfelder","year":"2011","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0147","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1089\/108076803322279426","article-title":"Ocular side-effects associated with imatinib mesylate (Gleevec)","volume":"19","author":"Fraunfelder","year":"2003","journal-title":"J Ocul Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0148","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0002-9394(14)76743-1","article-title":"Interferon alpha 2A for treatment of age-related macular degeneration","volume":"112","author":"Fung","year":"1991","journal-title":"Am J Ophthalmol"},{"issue":"15","key":"10.1016\/j.survophthal.2021.05.007_bib0149","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1007\/s40265-015-0477-8","article-title":"Cobimetinib: First global approval","volume":"75","author":"KP","year":"2015","journal-title":"Drugs."},{"issue":"24","key":"10.1016\/j.survophthal.2021.05.007_bib0150","first-page":"8742","article-title":"Tamoxifen inhibits secretion of vascular endothelial growth factor in breast cancer in vivo","volume":"63","author":"Garvin","year":"2003","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0151","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/0002-9394(73)90738-1","article-title":"Nicotinic acid maculopathy","volume":"76","author":"Gass","year":"1973","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.007_bib0152","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/jnci\/88.5.224","article-title":"Tamoxifen induction of apoptosis in estrogen receptor-negative cancers: New tricks for an old dog?","volume":"88","author":"Gelmann","year":"1996","journal-title":"J Natl Cancer Inst"},{"issue":"39","key":"10.1016\/j.survophthal.2021.05.007_bib0153","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.2174\/1381612823666171004120152","article-title":"PD-1\/PD-L1 inhibitors for immuno-oncology: From antibodies to small molecules","volume":"23","author":"Geng","year":"2018","journal-title":"Curr Pharm Des"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0154","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1444-0938.2011.00672.x","article-title":"Angiographically silent cystoid macular oedema secondary to paclitaxel therapy","volume":"95","author":"Georgakopoulos","year":"2012","journal-title":"Clin Exp Optom"},{"issue":"10","key":"10.1016\/j.survophthal.2021.05.007_bib0155","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s00417-007-0600-y","article-title":"Bilateral cystoid macular edema in a patient with chronic myeloid leukaemia under treatment with imanitib mesylate: report of an unusual side effect","volume":"245","author":"Georgalas","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2021.05.007_bib0156","first-page":"420","article-title":"Ocular toxicity of tamoxifen","volume":"21","author":"Gerner","year":"1989","journal-title":"Ann Ophthalmol"},{"issue":"2675","key":"10.1016\/j.survophthal.2021.05.007_bib0157","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.103.2675.409","article-title":"The biological actions and therapeutic applications of the B-chloroethyl amines and sulfides","volume":"103","author":"Gilman","year":"1946","journal-title":"Science"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0158","first-page":"117","article-title":"Basic and clinical science course 12: Retina and Vitreous. 99","author":"GM","year":"1998","journal-title":"San Francisco: American Academy of ophthalmology"},{"issue":"12","key":"10.1016\/j.survophthal.2021.05.007_bib0159","first-page":"5147","article-title":"Drug and hormone sensitivity of estrogen receptor-positive and -negative human breast cancer cells in vitro","volume":"42","author":"Goldenberg","year":"1982","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0160","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/art.38282","article-title":"Drug-associated polymyalgia rheumatica\/giant cell arteritis occurring in two patients after treatment with ipilimumab, an antagonist of ctla-4","volume":"66","author":"Goldstein","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"28","key":"10.1016\/j.survophthal.2021.05.007_bib0161","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.3748\/wjg.v12.i28.4602","article-title":"Branch retinal vein thrombosis and visual loss probably associated with pegylated interferon therapy of chronic hepatitis C","volume":"12","author":"Goncalves","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0162","series-title":"Plasma retinol-binding protein","author":"Goodman","year":"1984"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0163","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1001\/jama.1946.02870380008004","article-title":"Nitrogen mustard therapy; use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders","volume":"132","author":"Goodman","year":"1946","journal-title":"J Am Med Assoc"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0164","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0002-9394(99)80190-1","article-title":"Long-term tamoxifen citrate use and potential ocular toxicity","volume":"125","author":"Gorin","year":"1998","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0165","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10792-007-9038-9","article-title":"Imatinib-induced optic neuritis in a patient of chronic myeloid leukemia","volume":"27","author":"Govind Babu","year":"2007","journal-title":"Int Ophthalmol"},{"issue":"31","key":"10.1016\/j.survophthal.2021.05.007_bib0166","doi-asserted-by":"crossref","first-page":"7794","DOI":"10.1200\/JCO.2005.04.937","article-title":"Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer","volume":"23","author":"Gradishar","year":"2005","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0167","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3171\/jns.1984.61.3.0423","article-title":"Intra-arterial BCNU chemotherapy for treatment of malignant gliomas of the central nervous system","volume":"61","author":"Greenberg","year":"1984","journal-title":"J Neurosurg"},{"issue":"9-10","key":"10.1016\/j.survophthal.2021.05.007_bib0168","first-page":"803","article-title":"Intra-arterial BCNU chemotherapy for the treatment of malignant gliomas of the central nervous system: A preliminary report","volume":"65","author":"Greenberg","year":"1981","journal-title":"Cancer Treat Rep"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0169","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/IOP.0000000000000075","article-title":"Cutaneous melanoma metastatic to the orbit: Review of 15 cases","volume":"30","author":"Greene","year":"2014","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0170","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0002-9394(87)90014-6","article-title":"Tamoxifen retinopathy at low dosage","volume":"104","author":"Griffiths","year":"1987","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0171","first-page":"261","article-title":"Ophthalmic and central nervous system complications following intracarotid BCNU (Carmustine)","volume":"1","author":"Grimson","year":"1981","journal-title":"J Clin Neuroophthalmol"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0172","article-title":"[MEK inhibitor-associated retinopathy under binimetinib treatment for cutaneous malignant melanoma]","author":"Groselli","year":"2020","journal-title":"Ophthalmologe"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0173","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ajo.2005.04.042","article-title":"Optical coherence tomography findings in tamoxifen retinopathy","volume":"140","author":"Gualino","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"10.1016\/j.survophthal.2021.05.007_bib0174","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1001\/jamaophthalmol.2014.3024","article-title":"Uveitis in patients with late-stage cutaneous melanoma treated with vemurafenib","volume":"132","author":"Guedj","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"35","key":"10.1016\/j.survophthal.2021.05.007_bib0175","doi-asserted-by":"crossref","first-page":"22367","DOI":"10.1074\/jbc.273.35.22367","article-title":"Endogenous FGF1-induced activation and synthesis of extracellular signal-regulated kinase 2 reduce cell apoptosis in retinal-pigmented epithelial cells","volume":"273","author":"Guillonneau","year":"1998","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0176","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jaapos.2003.08.005","article-title":"Intracranial hypertension secondary to all-trans retinoic acid treatment for leukemia: Diagnosis and management","volume":"7","author":"Guirgis","year":"2003","journal-title":"J aapos"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0177","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/15569527.2017.1361438","article-title":"The protective effect of fish oil against cisplatin induced eye damage in rats","volume":"37","author":"Gul Baykalir","year":"2018","journal-title":"Cutan Ocul Toxicol"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0178","first-page":"1375","article-title":"Retinal neovascularization and hemorrhage associated with the use of imatinib (Gleevec(\u00ae)) in a patient being treated for gastrointestinal stromal tumor (GIST)","volume":"32","author":"Gulati","year":"2012","journal-title":"Anticancer Res"},{"issue":"10","key":"10.1016\/j.survophthal.2021.05.007_bib0179","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/archopht.1992.01080220045019","article-title":"Systemic antiangiogenic therapy for choroidal neovascularization. What is the role of interferon alfa?","volume":"110","author":"Guyer","year":"1992","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0180","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/archopht.1993.01090030068041","article-title":"Interferon-associated retinopathy","volume":"111","author":"Guyer","year":"1993","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0181","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/20502877.2017.1314885","article-title":"Economics of Cancer Medicines: For Whose Benefit?","volume":"23","author":"Gyawali","year":"2017","journal-title":"New Bioeth"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0182","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12348-016-0082-3","article-title":"Bilateral neuroretinitis and anterior uveitis following ipilimumab treatment for metastatic melanoma","volume":"6","author":"Hahn","year":"2016","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0183","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/ICB.0000000000000143","article-title":"Cystoid macular edema and macular pigmentation associated with nab-Paclitaxel therapy","volume":"9","author":"Haider","year":"2015","journal-title":"Retin Cases Brief Rep"},{"issue":"11","key":"10.1016\/j.survophthal.2021.05.007_bib0184","doi-asserted-by":"crossref","DOI":"10.1002\/phar.1839","article-title":"A rare case of pembrolizumab-induced uveitis in a patient with metastatic melanoma","volume":"36","author":"Hanna","year":"2016","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0185","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF00167362","article-title":"Retinal changes induced by treatment with vincristine and vinblastine","volume":"31","author":"Hansson","year":"1972","journal-title":"Doc Ophthalmol"},{"issue":"8","key":"10.1016\/j.survophthal.2021.05.007_bib0186","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1073\/pnas.95.8.4663","article-title":"Functions of the two glutamate transporters GLAST and GLT-1 in the retina","volume":"95","author":"Harada","year":"1998","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"7287","key":"10.1016\/j.survophthal.2021.05.007_bib0187","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature08833","article-title":"RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth","volume":"464","author":"Hatzivassiliou","year":"2010","journal-title":"Nature"},{"issue":"30","key":"10.1016\/j.survophthal.2021.05.007_bib0188","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1200\/JCO.2012.43.4431","article-title":"Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up","volume":"30","author":"Haugnes","year":"2012","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.survophthal.2021.05.007_bib0189","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1158\/1078-0432.CCR-09-1920","article-title":"A phase II study of PD-0325901, an oral MEK inhibitor, in previously treated patients with advanced non-small cell lung cancer","volume":"16","author":"Haura","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0190","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/bjo.79.2.150","article-title":"Retinopathy and subconjunctival haemorrhage in patients with chronic viral hepatitis receiving interferon alfa","volume":"79","author":"Hayasaka","year":"1995","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0191","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/bjo.82.3.323","article-title":"Interferon associated retinopathy","volume":"82","author":"Hayasaka","year":"1998","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2021.05.007_bib0192","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1345\/aph.1Q363","article-title":"PLX4032): An orally available inhibitor of mutated BRAF for the treatment of metastatic melanoma","volume":"45","author":"Heakal","year":"2011","journal-title":"Ann Pharmacother"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0193","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0002-9394(14)70321-6","article-title":"Screening for ocular toxicity in asymptomatic patients treated with tamoxifen","volume":"117","author":"Heier","year":"1994","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0194","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0002-9394(01)00836-4","article-title":"Retinopathy associated with high-dose interferon alfa-2b therapy","volume":"131","author":"Hejny","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0195","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ctrv.2017.08.009","article-title":"Immune checkpoint blockade for unresectable or metastatic uveal melanoma: A systematic review","volume":"60","author":"Heppt","year":"2017","journal-title":"Cancer Treat Rev"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0196","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1039\/c3mt20251h","article-title":"In vitro studies on cisplatin focusing on kinetic aspects of intracellular chemistry by LC-ICP-MS","volume":"5","author":"Hermann","year":"2013","journal-title":"Metallomics"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0197","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/(SICI)1096-911X(199704)28:4<310::AID-MPO12>3.0.CO;2-G","article-title":"Retinal toxicity associated with cisplatin and etoposide in pediatric patients","volume":"28","author":"Hilliard","year":"1997","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0198","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.critrevonc.2016.03.014","article-title":"Cisplatin versus carboplatin: comparative review of therapeutic management in solid malignancies","volume":"102","author":"Ho","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0199","first-page":"580","article-title":"Combined choroidal and retinal ischemia during interferon therapy: Indocyanine green angiographic and microperimetric findings","volume":"118","author":"Hoerauf","year":"2000","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0200","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0025-7125(16)32365-3","article-title":"Treatment of adrenocortical carcinoma with o,p'-DDD","volume":"56","author":"Hoffman","year":"1972","journal-title":"Med Clin North Am"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0201","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/0002-9394(81)90240-3","article-title":"Corneal toxicity with systemic cytarabine","volume":"91","author":"Hopen","year":"1981","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0202","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pdpdt.2016.10.004","article-title":"The optical imaging and clinical features of tamoxifen associated macular hole: A case report and review of the literatures","volume":"17","author":"Hu","year":"2017","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0203","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1182\/blood.V72.2.567.567","article-title":"Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia","volume":"72","author":"Huang ME","year":"1988","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0204","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1089\/jop.2009.0060","article-title":"PD0325901, a mitogen-activated protein kinase kinase inhibitor, produces ocular toxicity in a rabbit animal model of retinal vein occlusion","volume":"25","author":"Huang","year":"2009","journal-title":"J Ocul Pharmacol Ther"},{"issue":"24","key":"10.1016\/j.survophthal.2021.05.007_bib0205","doi-asserted-by":"crossref","first-page":"9115","DOI":"10.1158\/0008-5472.CAN-04-2740","article-title":"Agents with selective estrogen receptor (ER) modulator activity induce apoptosis in vitro and in vivo in ER-negative glioma cells","volume":"64","author":"Hui","year":"2004","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0206","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ejca.2013.10.016","article-title":"Ocular adverse events of molecularly targeted agents approved in solid tumours: A systematic review","volume":"50","author":"Huillard","year":"2014","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0207","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0002-9343(66)90220-8","article-title":"Adrenal cortical carcinoma. Results of treatment with o,p'DDD in 138 patients","volume":"41","author":"Hutter","year":"1966","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0208","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/15569527.2019.1608227","article-title":"Comparative study between lutein and its liposomal form on cisplatin-induced retinal injury in rabbits","volume":"38","author":"Ibrahim","year":"2019","journal-title":"Cutan Ocul Toxicol"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.007_bib0209","first-page":"1038","article-title":"Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel","volume":"8","author":"Ibrahim","year":"2002","journal-title":"Clin Cancer Res"},{"issue":"25","key":"10.1016\/j.survophthal.2021.05.007_bib0210","doi-asserted-by":"crossref","first-page":"6019","DOI":"10.1200\/JCO.2005.11.013","article-title":"Multicenter phase II trial of ABI-007, an albumin-bound paclitaxel, in women with metastatic breast cancer","volume":"23","author":"Ibrahim","year":"2005","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0211","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/1097-0142(19930715)72:2<587::AID-CNCR2820720242>3.0.CO;2-V","article-title":"Severe vascular toxicity associated with cisplatin-based chemotherapy","volume":"72","author":"I\u00e7li","year":"1993","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0212","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0039-6257(89)90105-7","article-title":"Ocular complications of systemic cancer chemotherapy","volume":"34","author":"Imperia","year":"1989","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0213","first-page":"23","article-title":"[A case of cystic maculopathy during paclitaxel therapy]","volume":"114","author":"Ito","year":"2010","journal-title":"Nippon Ganka Gakkai Zasshi"},{"issue":"10","key":"10.1016\/j.survophthal.2021.05.007_bib0214","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1136\/bjo.85.10.1171","article-title":"Retinopathy in chronic hepatitis C patients during interferon treatment with ribavirin","volume":"85","author":"Jain","year":"2001","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"10.1016\/j.survophthal.2021.05.007_bib0215","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/S0161-6420(88)32955-6","article-title":"Niacin maculopathy","volume":"95","author":"Jampol","year":"1988","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0216","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/ICB.0000000000000093","article-title":"Intravitreal triamcinolone acetonide treatment of tamoxifen maculopathy with associated cystoid macular edema","volume":"9","author":"Jeng","year":"2015","journal-title":"Retin Cases Brief Rep"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0217","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3892\/ijmm_00000191","article-title":"MEK\/ERK pathway mediates UVB-induced AQP1 downregulation and water permeability impairment in human retinal pigment epithelial cells","volume":"23","author":"Jiang","year":"2009","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0218","first-page":"43","article-title":"Blepharoconjunctivitis associated with cancer chemotherapy","volume":"46","author":"Johnson","year":"1965","journal-title":"Trans Pac Coast Otoophthalmol Soc Annu Meet"},{"issue":"7","key":"10.1016\/j.survophthal.2021.05.007_bib0219","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/sj.bmt.1701913","article-title":"Optic disc and retinal microvasculopathy after high-dose chemotherapy and autologous hematopoietic progenitor cell support","volume":"24","author":"Johnson","year":"1999","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0220","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000357060","article-title":"Uveitis as a result of MAP kinase pathway inhibition","volume":"4","author":"Joshi","year":"2013","journal-title":"Case Rep Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.007_bib0221","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/archopht.125.5.709","article-title":"Paclitaxel maculopathy","volume":"125","author":"Joshi","year":"2007","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0222","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.pharmthera.2013.05.003","article-title":"Current status of local therapy in malignant gliomas\u2013a clinical review of three selected approaches","volume":"139","author":"Juratli","year":"2013","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0223","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0161-6420(81)35071-4","article-title":"Tamoxifen retinopathy. A clinicopathologic report","volume":"88","author":"Kaiser-Kupfer","year":"1981","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0224","first-page":"315","article-title":"Tamoxifen retinopathy","volume":"62","author":"Kaiser-Kupfer","year":"1978","journal-title":"Cancer Treat Rep"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0225","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/archopht.1986.01050130079024","article-title":"Abnormal retinal function associated with fenretinide, a synthetic retinoid","volume":"104","author":"Kaiser-Kupfer","year":"1986","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0226","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3341\/kjo.2012.26.2.147","article-title":"Pegylated interferon-associated severe retinopathy in a patient with chronic hepatitis","volume":"26","author":"Kang","year":"2012","journal-title":"Korean J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0227","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0022-4731(90)90003-B","article-title":"Review of the pharmacological properties of toremifene","volume":"36","author":"Kangas","year":"1990","journal-title":"J Steroid Biochem"},{"issue":"11","key":"10.1016\/j.survophthal.2021.05.007_bib0228","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jiac.2017.04.007","article-title":"Uveitis induced by programmed cell death protein 1 inhibitor therapy with nivolumab in metastatic melanoma patient","volume":"23","author":"Kanno","year":"2017","journal-title":"J Infect Chemother"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0229","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3171\/jns.1985.62.6.0823","article-title":"Supraophthalmic carotid infusion for brain chemotherapy. Experience with a new single-lumen catheter and maneuverable tip","volume":"62","author":"Kapp","year":"1985","journal-title":"J Neurosurg"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0230","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF00165165","article-title":"Supraophthalmic carotid infusion for recurrent glioma: rationale, technique, and preliminary results for cisplatin and BCNU","volume":"3","author":"Kapp","year":"1985","journal-title":"J Neurooncol"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0231","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/09273948.2016.1215473","article-title":"Bilateral Anterior Uveitis Associated with Nivolumab Therapy","volume":"26","author":"Karlin","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0232","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00041327-200306000-00005","article-title":"Persistent severe visual and electroretinographic abnormalities after intravenous Cisplatin therapy","volume":"23","author":"Katz","year":"2003","journal-title":"J Neuroophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0233","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.preteyeres.2008.09.003","article-title":"Blood-retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management","volume":"27","author":"Kaur","year":"2008","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0234","first-page":"309","article-title":"Retinal complications during interferon therapy for chronic hepatitis C","volume":"91","author":"Kawano","year":"1996","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.007_bib0235","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1080\/03639045.2019.1569024","article-title":"Nanodelivery of doxorubicin for age-related macular degeneration","volume":"45","author":"Kelly","year":"2019","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0236","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0161-6420(96)30728-8","article-title":"Retinopathy and optic neuropathy in bone marrow transplantation for breast cancer","volume":"103","author":"Khawly","year":"1996","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0237","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/leu.2015.326","article-title":"Interferon-alpha for the therapy of myeloproliferative neoplasms: Targeting the malignant clone","volume":"30","author":"Kiladjian","year":"2016","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0238","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ophtha.2019.10.038","article-title":"Prevalence and risk factors of tamoxifen retinopathy","volume":"127","author":"Kim","year":"2020","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.survophthal.2021.05.007_bib0239","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.1167\/iovs.13-13662","article-title":"Tamoxifen toxicity in cultured retinal pigment epithelial cells is mediated by concurrent regulated cell death mechanisms","volume":"55","author":"Kim","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Pt 6","key":"10.1016\/j.survophthal.2021.05.007_bib0240","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/eye.2000.258","article-title":"Presumed interferon-associated bilateral macular arterial branch obstruction","volume":"14","author":"Kiratli","year":"2000","journal-title":"Eye (Lond)"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0241","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000448730","article-title":"In vivo confocal microscopy in differentiating ipilimumab-induced anterior uveitis from metastatic uveal melanoma","volume":"7","author":"Kiratli","year":"2016","journal-title":"Case Rep Ophthalmol."},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0242","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.optm.2009.10.012","article-title":"Cotton wool spots as an indicator of methotrexate-induced blood dyscrasia","volume":"81","author":"Klemencic","year":"2010","journal-title":"Optometry"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0243","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s00417-004-1079-4","article-title":"The spectrum of retinal phenotypes caused by mutations in the ABCA4 gene","volume":"243","author":"Klevering","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2021.05.007_bib0244","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.2217\/fon-2015-0075","article-title":"Selumetinib for the treatment of metastatic uveal melanoma: Past and future perspectives","volume":"12","author":"Komatsubara","year":"2016","journal-title":"Future Oncol"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0245","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1200\/JCO.1989.7.2.168","article-title":"Pentostatin in the treatment of advanced hairy cell leukemia","volume":"7","author":"Kraut","year":"1989","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0246","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF01214648","article-title":"Electroretinographic findings in subjects after administration of fenretinide","volume":"91","author":"Krzeminski","year":"1995","journal-title":"Doc Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2021.05.007_bib0247","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1073\/pnas.88.11.4651","article-title":"Nitric oxide: An endogenous modulator of leukocyte adhesion","volume":"88","author":"Kubes","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0248","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s003470170204","article-title":"[Electrophysiological studies in breast carcinoma patients with tamoxifen retinopathy].","volume":"98","author":"Kuchenbecker","year":"2001","journal-title":"Ophthalmologe"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0249","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1167\/iovs.11-7972","article-title":"Attenuated glial reaction in experimental proliferative vitreoretinopathy treated with liposomal doxorubicin","volume":"53","author":"Kuo","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0250","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1212\/WNL.38.2.284","article-title":"Visual system toxicity following intra-arterial chemotherapy","volume":"38","author":"Kupersmith","year":"1988","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0251","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/sj.leu.2403364","article-title":"Visual disturbance due to retinal edema as a complication of imatinib","volume":"18","author":"Kusumi","year":"2004","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0252","first-page":"555","article-title":"Ocular toxicity caused by Paclitaxel in neonatal sprague-dawley rats","volume":"23","author":"Kuwata","year":"2009","journal-title":"In Vivo"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0253","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10792-012-9558-9","article-title":"The mystery of angiographically silent macular oedema due to taxanes","volume":"32","author":"Kuznetcova","year":"2012","journal-title":"Int Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0254","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ajo.2005.07.046","article-title":"Retinal ischemia with neovascularization in cisplatin related retinal toxicity","volume":"141","author":"Kwan","year":"2006","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0255","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10384-008-0561-7","article-title":"Optic disc edema as a possible complication of Imatinib mesylate (Gleevec)","volume":"52","author":"Kwon","year":"2008","journal-title":"Jpn J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0256","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/pds.4363","article-title":"Retinal vascular complications associated with interferon-ribavirin therapy for chronic hepatitis C: A population-based study","volume":"27","author":"Lai","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0257","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1097\/IAE.0000000000000053","article-title":"Choroidal thickness in diabetic retinopathy: The influence of antiangiogenic therapy","volume":"34","author":"La\u00edns","year":"2014","journal-title":"Retina"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0258","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/ICB.0000000000000573","article-title":"Serous retinopathy associated with cisplatin treatment","volume":"13","author":"Langevin","year":"2019","journal-title":"Retin Cases Brief Rep"},{"issue":"20","key":"10.1016\/j.survophthal.2021.05.007_bib0259","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1056\/NEJMoa1408868","article-title":"Combined vemurafenib and cobimetinib in BRAF-mutated melanoma","volume":"371","author":"Larkin","year":"2014","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0260","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0002-9394(98)00346-8","article-title":"Severe ocular and orbital toxicity after intracarotid etoposide phosphate and carboplatin therapy","volume":"127","author":"Lauer","year":"1999","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2021.05.007_bib0261","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s004170050139","article-title":"Tamoxifen retinopathy: Does it really exist?","volume":"236","author":"Lazzaroni","year":"1998","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0262","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1365-2133.2010.10185.x","article-title":"Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: A meta-analysis","volume":"164","author":"Lee","year":"2011","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.survophthal.2021.05.007_bib0263","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.oret.2019.03.014","article-title":"OCT angiography findings of tamoxifen retinopathy: Similarity with macular telangiectasia Type 2","volume":"3","author":"Lee","year":"2019","journal-title":"Ophthalmol Retina"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.007_bib0264","first-page":"839","article-title":"Growth factor responsiveness of human retinal pigment epithelial cells","volume":"31","author":"Leschey","year":"1990","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"15","key":"10.1016\/j.survophthal.2021.05.007_bib0265","first-page":"4112","article-title":"Effects of N-(4-hydroxyphenyl)retinamide supplementation on vitamin A metabolism","volume":"54","author":"Lewis","year":"1994","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.survophthal.2021.05.007_bib0266","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/0959-8049(96)00197-9","article-title":"Effects of chronic administration of N-(4-hydroxyphenyl)retinamide (4-HPR) in rats on vitamin A metabolism in the eye","volume":"32a","author":"Lewis","year":"1996","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0267","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000357912","article-title":"Unilateral optic disc papilloedema following administration of carboplatin chemotherapy for ovarian carcinoma","volume":"7","author":"Lewis","year":"2014","journal-title":"Case Rep Oncol"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0268","first-page":"1361","article-title":"Paclitaxel- and\/or cisplatin-induced ocular neurotoxicity: A case report and literature review","volume":"7","author":"Li","year":"2014","journal-title":"Onco Targets Ther"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.007_bib0269","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000226049","article-title":"Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy","volume":"42","author":"Licciardello","year":"1985","journal-title":"Oncology"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0270","first-page":"628","article-title":"Uveitis and papillitis in the setting of dabrafenib and trametinib therapy for metastatic melanoma: A case report","volume":"26","author":"Lim","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0271","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000260228","article-title":"Pegylated-interferon-associated retinopathy in chronic hepatitis patients","volume":"224","author":"Lim","year":"2010","journal-title":"Ophthalmologica"},{"issue":"7","key":"10.1016\/j.survophthal.2021.05.007_bib0272","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/IAE.0000000000000242","article-title":"Retinal toxicities of cancer therapy drugs: Biologics, small molecule inhibitors, and chemotherapies","volume":"34","author":"Liu","year":"2014","journal-title":"Retina"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.007_bib0273","doi-asserted-by":"crossref","first-page":"704","DOI":"10.7326\/0003-4819-100-5-704","article-title":"Drugs 5 years later. Cisplatin","volume":"100","author":"Loehrer","year":"1984","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.survophthal.2021.05.007_bib0274","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1200\/JCO.2010.32.4327","article-title":"Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma","volume":"29","author":"Long","year":"2011","journal-title":"J Clin Oncol"},{"issue":"20","key":"10.1016\/j.survophthal.2021.05.007_bib0275","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1056\/NEJMoa1406037","article-title":"Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma","volume":"371","author":"Long","year":"2014","journal-title":"N Engl J Med"},{"issue":"9992","key":"10.1016\/j.survophthal.2021.05.007_bib0276","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0140-6736(15)60898-4","article-title":"Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: A multicentre, double-blind, phase 3 randomized controlled trial","volume":"386","author":"Long","year":"2015","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0277","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1158\/1078-0432.CCR-09-1883","article-title":"Phase I pharmacokinetic and pharmacodynamic study of the oral MAPK\/ERK kinase inhibitor PD-0325901 in patients with advanced cancers","volume":"16","author":"LoRusso","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0278","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00417-017-3619-8","article-title":"Novel therapeutics for Stargardt disease","volume":"255","author":"Lu","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0279","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1080\/10428190701843254","article-title":"Denilieukin diftitox vision loss is not posterior ischemic optic neuropathy","volume":"49","author":"Lubow","year":"2008","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"10.1016\/j.survophthal.2021.05.007_bib0280","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrclinonc.2017.43","article-title":"Targeted agents and immunotherapies: Optimizing outcomes in melanoma","volume":"14","author":"Luke","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0281","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2147\/DHPS.S39568","article-title":"New developments in the treatment of metastatic melanoma - role of dabrafenib-trametinib combination therapy","volume":"6","author":"Luke","year":"2014","journal-title":"Drug Healthc Patient Saf"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0282","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0041-008X(81)90014-4","article-title":"Tamoxifen-induced generalized lipidosis in rats subchronically treated with high doses","volume":"61","author":"Lullmann","year":"1981","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0283","first-page":"185","article-title":"Drug-induced phospholipidoses. II. Tissue distribution of the amphiphilic drug chlorphentermine","volume":"4","author":"Lullmann","year":"1975","journal-title":"CRC Crit Rev Toxicol"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0284","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1034\/j.1600-0773.2002.910305.x","article-title":"Glutamate uptake is inhibited by tamoxifen and toremifene in cultured retinal pigment epithelial cells","volume":"91","author":"M\u00e4enp\u00e4\u00e4","year":"2002","journal-title":"Pharmacol Toxicol"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0285","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1001\/archneur.1992.00530250087021","article-title":"Intra-arterial cisplatin\u2013associated optic and otic toxicity","volume":"49","author":"Maiese","year":"1992","journal-title":"Arch Neurol"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0286","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejca.2017.05.041","article-title":"Myasthenia gravis: An emerging toxicity of immune checkpoint inhibitors","volume":"82","author":"Makarious","year":"2017","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.007_bib0287","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/hep.510270533","article-title":"Neurovisual impairment: A frequent complication of alpha-interferon treatment in chronic viral hepatitis","volume":"27","author":"Manesis","year":"1998","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.survophthal.2021.05.007_bib0288","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1001\/jamaophthalmol.2015.1128","article-title":"Bilateral Choroidopathy and serous retinal detachments during ipilimumab treatment for cutaneous melanoma","volume":"133","author":"Mantopoulos","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0289","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/1097-0142(197701)39:1<58::AID-CNCR2820390111>3.0.CO;2-5","article-title":"Blindness during remission in two patients with acute lymphoblastic leukemia: A possible complication of multimodality therapy","volume":"39","author":"Margileth","year":"1977","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0290","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0002-9394(14)71417-5","article-title":"Ocular and orbital toxicity after intracarotid cisplatin therapy","volume":"116","author":"Margo","year":"1993","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.007_bib0291","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1177\/030089169608200506","article-title":"Chemoprevention of breast cancer with fenretinide (4-HPR): Study of long-term visual and ophthalmologic tolerability","volume":"82","author":"Mariani","year":"1996","journal-title":"Tumori"},{"issue":"9","key":"10.1016\/j.survophthal.2021.05.007_bib0292","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s40265-020-01331-x","article-title":"Selumetinib: First approval","volume":"80","author":"Markham","year":"2020","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0293","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10633-008-9132-y","article-title":"Total rod ERG suppression with high dose compassionate Fenretinide usage","volume":"117","author":"Marmor","year":"2008","journal-title":"Doc Ophthalmol"},{"issue":"1-2","key":"10.1016\/j.survophthal.2021.05.007_bib0294","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jneuroim.2010.12.008","article-title":"Protein kinases JAK and ERK mediate protective effect of interleukin-2 upon ganglion cells of the developing rat retina","volume":"233","author":"Marra","year":"2011","journal-title":"J Neuroimmunol"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0295","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/ICB.0b013e31814b160d","article-title":"Interferon-\u03b2-associated retinopathy","volume":"3","author":"Martinez de Aragon","year":"2009","journal-title":"Retin Cases Brief Rep"},{"issue":"7","key":"10.1016\/j.survophthal.2021.05.007_bib0296","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/00001813-199808000-00001","article-title":"Tamoxifen as a potential treatment of glioma","volume":"9","author":"Mastronardi","year":"1998","journal-title":"Anticancer Drugs"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0297","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/IAE.0b013e318265801d","article-title":"Investigation of oral fenretinide for treatment of geographic atrophy in age-related macular degeneration","volume":"33","author":"Mata","year":"2013","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0298","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0896-6273(02)00912-1","article-title":"Isomerization and oxidation of vitamin a in cone-dominant retinas: A novel pathway for visual-pigment regeneration in daylight","volume":"36","author":"Mata","year":"2002","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0299","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10549-006-9187-y","article-title":"Optical coherence tomography in tamoxifen retinopathy","volume":"99","author":"Mauget-Faysse","year":"2006","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"10.1016\/j.survophthal.2021.05.007_bib0300","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1001\/jamaophthalmol.2014.976","article-title":"Bilateral subfoveal neurosensory retinal detachment associated with MEK inhibitor use for metastatic cancer","volume":"132","author":"McCannel","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0301","doi-asserted-by":"crossref","first-page":"897","DOI":"10.5301\/ejo.5000509","article-title":"Effect of anti-VEGF treatment on choroidal thickness over time in patients with neovascular age-related macular degeneration","volume":"24","author":"McDonnell","year":"2014","journal-title":"Eur J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0302","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/bjo.65.3.177","volume":"65","author":"McKeown","year":"1981","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.007_bib0303","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1182\/blood.V57.5.946.946","article-title":"Evidence for the inhibitory role of guanosine 3\u2032, 5\u2032-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators","volume":"57","author":"Mellion","year":"1981","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.survophthal.2021.05.007_bib0304","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/IAE.0000000000002451","article-title":"Ocular adverse events associated with MEK inhibitors","volume":"39","author":"Mendez-Martinez","year":"2019","journal-title":"Retina"},{"issue":"8","key":"10.1016\/j.survophthal.2021.05.007_bib0305","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1158\/1078-0432.CCR-13-2054","article-title":"Dabrafenib and trametinib, alone and in combination for BRAF-mutant metastatic melanoma","volume":"20","author":"Menzies","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.007_bib0306","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3928\/23258160-20160419-17","article-title":"Choroidal metastases from cutaneous melanoma","volume":"47","author":"Mercado","year":"2016","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0307","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00417-011-1642-8","article-title":"Regression of paclitaxel-induced maculopathy with oral acetazolamide","volume":"250","author":"Meyer","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2021.05.007_bib0308","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0161-6420(88)33073-3","article-title":"Niacin maculopathy","volume":"95","author":"Millay","year":"1988","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.007_bib0309","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/0002-9394(86)90536-2","article-title":"Maculopathy associated with combination chemotherapy and osmotic opening of the blood-brain barrier","volume":"102","author":"Millay","year":"1986","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0310","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0161-6420(85)34036-8","article-title":"Ocular and orbital toxicity following intracarotid injection of BCNU (carmustine) and cisplatinum for malignant gliomas","volume":"92","author":"Miller","year":"1985","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0311","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/j.jcjo.2014.10.010","article-title":"New-onset uveitis during CTLA-4 blockade therapy with ipilimumab in metastatic melanoma patient","volume":"50","author":"Miserocchi","year":"2015","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0312","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ajoc.2018.03.010","article-title":"Vogt-Koyanagi-Harada disease like presentation in patients with chronic myeloid leukemia","volume":"10","author":"Mistry","year":"2018","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.007_bib0313","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10792-011-9476-2","article-title":"Reversible branch retinal artery occlusion following intravenous cisplatin chemotherapy for cervical carcinoma","volume":"31","author":"Mitra","year":"2011","journal-title":"Int Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0314","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/BF00171846","article-title":"Phase II study of fenretinide (N-[4-hydroxyphenyl]retinamide) in advanced breast cancer and melanoma","volume":"8","author":"Modiano","year":"1990","journal-title":"Invest New Drugs"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0315","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/15569527.2013.781618","article-title":"Multifocal bilateral choroidal neovascularization in a patient on ipilimumab for metastatic melanoma","volume":"32","author":"Modjtahedi","year":"2013","journal-title":"Cutan Ocul Toxicol"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.007_bib0316","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/jamaophthalmol.2017.0275","article-title":"MEKanisms of a Serous Complication","volume":"135","author":"Montana","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"25","key":"10.1016\/j.survophthal.2021.05.007_bib0317","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1200\/JCO.2011.35.5669","article-title":"High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: A large retrospective analysis","volume":"29","author":"Moore","year":"2011","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0318","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10384-008-0585-z","article-title":"Central retinal vein occlusion in hypertensive patients with chronic hepatitis C treated with interferon alpha and ribavirin","volume":"52","author":"Murata","year":"2008","journal-title":"Jpn J Ophthalmol"},{"issue":"33","key":"10.1016\/j.survophthal.2021.05.007_bib0319","doi-asserted-by":"crossref","first-page":"e684","DOI":"10.1200\/JCO.2010.30.3750","article-title":"Cystoid macular edema secondary to nab-paclitaxel therapy","volume":"28","author":"Murphy","year":"2010","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.survophthal.2021.05.007_bib0320","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2174\/092986707780598023","article-title":"Medicinal chemistry and emerging strategies applied to the development of selective estrogen receptor modulators (SERMs)","volume":"14","author":"Musa","year":"2007","journal-title":"Curr Med Chem"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0321","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1167\/iovs.06-0182","article-title":"Retinal circulatory changes associated with interferon-induced retinopathy in patients with hepatitis C","volume":"48","author":"Nagaoka","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.survophthal.2021.05.007_bib0322","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1093\/annonc\/mdv383","article-title":"Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies","volume":"26","author":"Naidoo","year":"2015","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0323","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1089\/jop.2012.0050","article-title":"The eyes have it! Tamoxifen maculopathy revisited: A case report","volume":"28","author":"Nair","year":"2012","journal-title":"J Ocul Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0324","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/ICB.0b013e31825956f1","article-title":"Spectral domain optical coherence tomography findings in tamoxifen retinopathy\u2013a case report","volume":"7","author":"Nair","year":"2013","journal-title":"Retin Cases Brief Rep"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0325","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3928\/23258160-20151214-14","article-title":"Possibility of m\u00fcller cell dysfunction as the pathogenesis of paclitaxel maculopathy","volume":"47","author":"Nakao","year":"2016","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"8","key":"10.1016\/j.survophthal.2021.05.007_bib0326","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.6004\/jnccn.2014.0105","article-title":"Ipilimumab-induced hypophysitis and uveitis in a patient with metastatic melanoma and a history of ipilimumab-induced skin rash","volume":"12","author":"Nallapaneni","year":"2014","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0327","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000455266","article-title":"Intracellular Edema","volume":"58","author":"Narayanan","year":"2017","journal-title":"Dev Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0328","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1200\/JCO.1996.14.3.1018","article-title":"Tamoxifen-associated eye disease. A review","volume":"14","author":"Nayfield","year":"1996","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0329","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1097\/OPX.0000000000000478","article-title":"Spectral Domain OCT imaging techniques in tamoxifen retinopathy","volume":"92","author":"Neuville","year":"2015","journal-title":"Optom Vis Sci"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0330","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/bjo.87.4.500-a","article-title":"Pigmentary retinopathy, macular oedema, and abnormal ERG with mitotane treatment","volume":"87","author":"Ng","year":"2003","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0331","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1177\/112067210501500626","article-title":"Branch retinal artery occlusion combined with branch retinal vein occlusion in a patient with hepatitis C treated with interferon and ribavirin","volume":"15","author":"Nicolo","year":"2005","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0332","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40942-015-0017-4","article-title":"Safe dose of intravitreal imatinib and its effect on laser-induced choroidal neovascularization: a rat-model experiment","volume":"1","author":"Nikkhah","year":"2015","journal-title":"Int J Retina Vitreous"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.007_bib0333","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.ajo.2015.07.035","article-title":"ocular toxicity in metastatic melanoma patients treated with mitogen-activated protein kinase kinase inhibitors: A case series","volume":"160","author":"Niro","year":"2015","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0334","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1001\/archopht.1996.01100130718014","article-title":"Interferon alfa induces leukocyte capillary trapping in rat retinal microcirculation","volume":"114","author":"Nishiwaki","year":"1996","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.007_bib0335","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3928\/23258160-20160419-01","article-title":"Retinal toxicity associated with MEK inhibitor use for metastatic cancer: A rising trend in ophthalmology","volume":"47","author":"Nolan","year":"2016","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0336","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3928\/0191-3913-19790501-15","article-title":"Unilateral optic neuropathy following vincristine chemotherapy","volume":"16","author":"Norton","year":"1979","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"16","key":"10.1016\/j.survophthal.2021.05.007_bib0337","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1021\/bi00468a012","article-title":"Interactions of retinol with binding proteins: Implications for the mechanism of uptake by cells","volume":"29","author":"Noy","year":"1990","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0338","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/IAE.0000000000002027","article-title":"Frequent subclinical macular changes in combined BRAF\/MEK inhibition with high-dose hydroxychloroquine as treatment for advanced metastatic braf mutant melanoma: Preliminary results from a Phase I\/II Clinical treatment trial","volume":"39","author":"Nti","year":"2019","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0339","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/1346-8138.13779","article-title":"Bilateral anterior uveitis and unilateral facial palsy due to ipilimumab for metastatic melanoma in an individual with human leukocyte antigen DR4: A case report","volume":"45","author":"Numata","year":"2018","journal-title":"J Dermatol"},{"issue":"8792","key":"10.1016\/j.survophthal.2021.05.007_bib0340","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/0140-6736(92)90384-F","article-title":"Blindness associated with high-dose carboplatin","volume":"339","author":"O'Brien","year":"1992","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0341","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.survophthal.2003.08.005","article-title":"Bilateral diffuse uveal melanocytic proliferation associated with pancreatic carcinoma: A case report and literature review of this paraneoplastic syndrome","volume":"48","author":"O'Neal","year":"2003","journal-title":"Surv Ophthalmol"},{"issue":"23","key":"10.1016\/j.survophthal.2021.05.007_bib0342","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.3748\/wjg.v12.i23.3756","article-title":"Risk factors for retinopathy associated with interferon alpha-2b and ribavirin combination therapy in patients with chronic hepatitis C","volume":"12","author":"Okuse","year":"2006","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0343","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00006982-198202040-00020","article-title":"The toxic effects of glutamate and related compounds in the retina and the brain","volume":"2","author":"Olney","year":"1982","journal-title":"Retina"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0344","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1200\/JCO.2001.19.2.376","article-title":"Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma","volume":"19","author":"Olsen","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0345","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1186\/s12885-015-1969-3","article-title":"Trastuzumab-induced corneal ulceration: Successful no-drug treatment of a \"blind\" side effect in a case report","volume":"15","author":"Orlandi","year":"2015","journal-title":"BMC Cancer"},{"issue":"10","key":"10.1016\/j.survophthal.2021.05.007_bib0346","first-page":"1591","article-title":"Ophthalmologic toxicity after cis-dichlorodiammineplatinum(II) therapy","volume":"62","author":"Ostrow","year":"1978","journal-title":"Cancer Treat Rep"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0347","first-page":"140","article-title":"Ipilimumab-induced Ocular and Orbital Inflammation\u2013A case series and review of the literature","volume":"24","author":"Papavasileiou","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0348","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1080\/10428190701268783","article-title":"Vision loss following denileukin diftitox treatment: A case report of possible posterior ischemic optic neuropathy","volume":"48","author":"Park","year":"2007","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0349","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/ICB.0b013e31815e93cf","article-title":"Microcystoid maculopathy associated with tamoxifen use diagnosed by high-resolution fourier-domain optical coherence tomography","volume":"3","author":"Park","year":"2009","journal-title":"Retin Cases Brief Rep"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0350","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00281-008-0112-9","article-title":"Immunopathological aspects of age-related macular degeneration","volume":"30","author":"Patel","year":"2008","journal-title":"Semin Immunopathol"},{"issue":"12","key":"10.1016\/j.survophthal.2021.05.007_bib0351","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1002\/1097-0142(19920615)69:12<2961::AID-CNCR2820691215>3.0.CO;2-W","article-title":"Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity. A prospective study of 63 patients","volume":"69","author":"Pavlidis","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0352","first-page":"88","article-title":"Endothelial cells and circulating neutrophil leukocytes","volume":"13","author":"Pearson","year":"1983","journal-title":"Curr Probl Clin Biochem"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0353","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ijc.2910430106","article-title":"Pharmacokinetics of N-4-hydroxyphenyl-retinamide and the effect of its oral administration on plasma retinol concentrations in cancer patients","volume":"43","author":"Peng","year":"1989","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0354","first-page":"353","article-title":"Experimental retinal dysplasia due to cytosine arabinoside","volume":"16","author":"Percy","year":"1977","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.007_bib0355","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0168-8278(02)00243-X","article-title":"Visual loss during interferon-alpha therapy in hepatitis C virus infection","volume":"37","author":"Perlemuter","year":"2002","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0356","first-page":"87","article-title":"Ischemic optic neuropathy secondary to intracarotid infusion of BCNU","volume":"7","author":"Pickrell","year":"1987","journal-title":"J Clin Neuroophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0357","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0090-8258(81)90155-4","article-title":"Cisplatin-associated cortical blindness","volume":"12","author":"Pippitt","year":"1981","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0358","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/0002-9394(69)90722-3","article-title":"Lens changes in chronic granulocytic leukemia. Possible relationship to chemotherapy","volume":"68","author":"Podos","year":"1969","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0359","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/15569527.2014.999080","article-title":"Toxic effects of systemic cisplatin on rat eyes and the protective effect of hesperidin against this toxicity","volume":"35","author":"Polat","year":"2016","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0360","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-1-4614-0631-0_23","article-title":"The mechanism of fenretinide (4-HPR) inhibition of \u03b2-Carotene monooxygenase 1. New suspect for the visual side effects of fenretinide","volume":"723","author":"Poliakov","year":"2012","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0361","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1046\/j.1600-0420.2003.00181.x","article-title":"Reduced full-field electroretinogram (ERG) in a patient treated with methotrexate","volume":"82","author":"Ponjavic","year":"2004","journal-title":"Acta Ophthalmol Scand"},{"issue":"8828","key":"10.1016\/j.survophthal.2021.05.007_bib0362","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/0140-6736(92)93162-G","article-title":"The case for clinical trials of tamoxifen for prevention of breast cancer","volume":"340","author":"Powles","year":"1992","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.survophthal.2021.05.007_bib0363","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1016\/j.ophtha.2010.04.001","article-title":"Perifoveal m\u00fcller cell depletion in a case of macular telangiectasia type 2","volume":"117","author":"Powner","year":"2010","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0364","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jamaoncol.2016.4213","article-title":"Ocular toxicity of mitogen-activated protein kinase inhibitors","volume":"3","author":"Purbrick","year":"2017","journal-title":"JAMA Oncol"},{"issue":"8","key":"10.1016\/j.survophthal.2021.05.007_bib0365","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1001\/archopht.1995.01100080093034","article-title":"Anterior ischemic optic neuropathy secondary to interferon alfa","volume":"113","author":"Purvin","year":"1995","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0366","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1476-5381.1992.tb14517.x","article-title":"S-nitroso-glutathione inhibits platelet activation in vitro and in vivo","volume":"107","author":"Radomski","year":"1992","journal-title":"Br J Pharmacol"},{"issue":"12","key":"10.1016\/j.survophthal.2021.05.007_bib0367","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1167\/iovs.05-0820","article-title":"Reductions in serum vitamin A arrest accumulation of toxic retinal fluorophores: A potential therapy for treatment of lipofuscin-based retinal diseases","volume":"46","author":"Radu","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.survophthal.2021.05.007_bib0368","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/archophthalmol.2011.2741","article-title":"Bevacizumab therapy for tamoxifen-induced crystalline retinopathy and severe cystoid macular edema","volume":"130","author":"Rahimy","year":"2012","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0369","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1210\/endo.136.2.7835285","article-title":"Differential positive and negative transcriptional regulation by tamoxifen","volume":"136","author":"Ramkumar","year":"1995","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0370","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.bulcan.2016.11.011","article-title":"[50th anniversary of cisplatin]","volume":"104","author":"Rancoule","year":"2017","journal-title":"Bull Cancer"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0371","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/oxfordjournals.annonc.a058497","article-title":"Ophthalmic toxicity during carboplatin therapy","volume":"4","author":"Rankin","year":"1993","journal-title":"Ann Oncol"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0372","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1186\/1752-1947-6-408","article-title":"Pseudotumor cerebri presenting with visual failure in promyelocytic leukemia: A case report","volume":"6","author":"Rasul","year":"2012","journal-title":"J Med Case Rep"},{"issue":"5794","key":"10.1016\/j.survophthal.2021.05.007_bib0373","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/bmj.1.5794.218","article-title":"Cataract after busulphan treatment","volume":"1","author":"Ravindranathan","year":"1972","journal-title":"Br Med J"},{"issue":"9","key":"10.1016\/j.survophthal.2021.05.007_bib0374","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1177\/153537020122600903","article-title":"Drug-induced phospholipidosis: are there functional consequences?","volume":"226","author":"Reasor","year":"2001","journal-title":"Exp Biol Med (Maywood)"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0375","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/ICB.0000000000000675","article-title":"Immune retinopathy associated with nivolumab administration for metastatic non-small cell lung cancer","volume":"14","author":"Reddy","year":"2020","journal-title":"Retin Cases Brief Rep"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.007_bib0376","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0305-7372(98)90056-1","article-title":"Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy","volume":"24","author":"Reed","year":"1998","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0377","series-title":"Platinum analogues. Cancer Chemotherapy","author":"Reed E","year":"1996"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0378","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00417-018-04209-7","article-title":"Interferon-alpha-induced retinopathy in chronic hepatitis C treatment: summary, considerations, and recommendations","volume":"257","author":"Rentiya","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2021.05.007_bib0379","first-page":"1183","article-title":"Bilateral uveitis associated with nivolumab therapy for metastatic melanoma: A case report","volume":"10","author":"Richardson","year":"2017","journal-title":"Int J Ophthalmol"},{"issue":"22","key":"10.1016\/j.survophthal.2021.05.007_bib0380","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1200\/JCO.2004.01.185","article-title":"Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer","volume":"22","author":"Rinehart","year":"2004","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0381","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1111\/j.1471-4159.2005.03129.x","article-title":"Fibroblast growth factor 2 applied to the optic nerve after axotomy increases Bcl-2 and decreases Bax in ganglion cells by activating the extracellular signal-regulated kinase signaling pathway","volume":"93","author":"R\u00edos-Mu\u00f1oz","year":"2005","journal-title":"J Neurochem"},{"issue":"7","key":"10.1016\/j.survophthal.2021.05.007_bib0382","first-page":"787","article-title":"Functional abnormalities in vincristine-induced night blindness","volume":"25","author":"Ripps","year":"1984","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0383","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/ICB.0b013e318193492c","article-title":"Cystoid macular edema secondary to Paclitaxel (abraxane)","volume":"3","author":"Risard","year":"2009","journal-title":"Retin Cases Brief Rep"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0384","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s00347-007-1677-8","article-title":"[Tamoxifen retinopathy: a case series of clinical and functional data]","volume":"105","author":"Ritter","year":"2008","journal-title":"Ophthalmologe"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0385","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cytogfr.2014.10.002","article-title":"Role of type I interferon in inducing a protective immune response: Perspectives for clinical applications","volume":"26","author":"Rizza","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0386","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1056\/NEJMoa1412690","article-title":"Improved overall survival in melanoma with combined dabrafenib and trametinib","volume":"372","author":"Robert","year":"2015","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0387","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/00002371-200411000-00008","article-title":"Cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma: A new cause of uveitis","volume":"27","author":"Robinson","year":"2004","journal-title":"J Immunother"},{"issue":"25","key":"10.1016\/j.survophthal.2021.05.007_bib0388","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1056\/NEJMc1111672","article-title":"Vemurafenib for melanoma metastases to the brain","volume":"365","author":"Rochet","year":"2011","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0389","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/ICB.0b013e318177f9d7","article-title":"Macular ischemia associated with imatinib mesylate therapy for chronic myeloid leukemia","volume":"3","author":"Roth","year":"2009","journal-title":"Retin Cases Brief Rep"},{"issue":"9","key":"10.1016\/j.survophthal.2021.05.007_bib0390","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/0277-5379(91)90309-2","article-title":"Long-term tolerability of fenretinide (4-HPR) in breast cancer patients","volume":"27","author":"Rotmensz","year":"1991","journal-title":"Eur J Cancer"},{"issue":"15","key":"10.1016\/j.survophthal.2021.05.007_bib0391","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJM199504133321507","article-title":"Paclitaxel (taxol)","volume":"332","author":"Rowinsky","year":"1995","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0392","first-page":"253","article-title":"Ocular toxicity following high dose chemotherapy and autologous transplant","volume":"18","author":"Rubin","year":"1996","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0393","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/00006982-200308000-00019","article-title":"Interferon-associated combined branch retinal artery and central retinal vein obstruction","volume":"23","author":"Rubio","year":"2003","journal-title":"Retina"},{"issue":"8","key":"10.1016\/j.survophthal.2021.05.007_bib0394","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/bjo.2006.091165","article-title":"A denileukin diftitox (Ontak) associated retinopathy?","volume":"90","author":"Ruddle","year":"2006","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2021.05.007_bib0395","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.oftal.2018.01.008","article-title":"Uveitis and serous retinal detachment secondary to systemic dabrafenib and trametinib","volume":"93","author":"Rueda-Rueda","year":"2018","journal-title":"Arch Soc Esp Oftalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0396","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3928\/15428877-20090430-17","article-title":"Progression of macular ischemia following intravitreal bevacizumab","volume":"40","author":"Sabet-Peyman","year":"2009","journal-title":"Ophthalmic Surg Lasers Imaging"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0397","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1034\/j.1600-0676.2001.021003192.x","article-title":"Interferon-associated retinopathy in a uniform regimen of natural interferon-alpha therapy for chronic hepatitis C","volume":"21","author":"Saito","year":"2001","journal-title":"Liver"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0398","first-page":"321","article-title":"Ocular lesions induced in infant rats by busulfan","volume":"30","author":"Saito","year":"2015","journal-title":"Histol Histopathol"},{"issue":"15","key":"10.1016\/j.survophthal.2021.05.007_bib0399","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1158\/1078-0432.CCR-05-2447","article-title":"Cutaneous melanoma subtypes show different BRAF and NRAS mutation frequencies","volume":"12","author":"Saldanha","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0400","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3109\/0284186X.2011.555781","article-title":"Bilateral macular ischemia and severe visual loss following trastuzumab therapy","volume":"50","author":"Saleh","year":"2011","journal-title":"Acta Oncol"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0401","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/02713680701229638","article-title":"Multifocal electroretinography, color discrimination and ocular toxicity in tamoxifen use","volume":"32","author":"Salomao","year":"2007","journal-title":"Curr Eye Res"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0402","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/jcp.20774","article-title":"N-(4-hydroxyphenyl)retinamide induces apoptosis in human retinal pigment epithelial cells: retinoic acid receptors regulate apoptosis, reactive oxygen species generation, and the expression of heme oxygenase-1 and Gadd153","volume":"209","author":"Samuel","year":"2006","journal-title":"J Cell Physiol"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0403","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0002-9394(76)90725-X","article-title":"Optic neuropathy presumably caused by vincristine therapy","volume":"81","author":"Sanderson","year":"1976","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0404","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1212\/WNL.19.4.367","article-title":"Vincristine-induced neuropathy. A clinical study of fifty leukemic patients","volume":"19","author":"Sandler","year":"1969","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0405","first-page":"1","article-title":"Etoposide phosphate: What, why, where, and how?","volume":"23","author":"Schacter","year":"1996","journal-title":"Semin Oncol"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0406","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1158\/1078-0432.CCR-09-1766","article-title":"Mitogen-activated protein\/extracellular signal-regulated kinase kinase inhibition results in biphasic alteration of epidermal homeostasis with keratinocytic apoptosis and pigmentation disorders","volume":"16","author":"Schad","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0407","doi-asserted-by":"crossref","first-page":"929","DOI":"10.7326\/0003-4819-90-6-929","article-title":"Hypomagnesemia and renal magnesium wasting in patients receiving cisplatin","volume":"90","author":"Schilsky","year":"1979","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0408","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.survophthal.2005.11.001","article-title":"Update on ocular complications of systemic cancer chemotherapy","volume":"51","author":"Schmid","year":"2006","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0409","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF02307266","article-title":"Drug-induced lysosomal disorders in laboratory animals: new substances acting on lysosomes","volume":"66","author":"Schneider","year":"1992","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0410","article-title":"Bilateral multifocal central serous-like chorioretinopathy due to MEK inhibition for metastatic cutaneous melanoma","volume":"2013","author":"Schoenberger","year":"2013","journal-title":"Case Rep Ophthalmol Med"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0411","first-page":"81","article-title":"Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy","volume":"139","author":"Schr\u00f6der","year":"1991","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0412","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0161-6420(02)01741-4","article-title":"Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin","volume":"110","author":"Schulman","year":"2003","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.survophthal.2021.05.007_bib0413","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nrc1503","article-title":"Targeting the mitogen-activated protein kinase cascade to treat cancer","volume":"4","author":"Sebolt-Leopold","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"10.1016\/j.survophthal.2021.05.007_bib0414","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1200\/JCO.1994.12.8.1741","article-title":"Photopsia during 3-hour paclitaxel administration at doses >or\u00a0=\u00a0250 mg\/m2","volume":"12","author":"Seidman","year":"1994","journal-title":"J Clin Oncol"},{"issue":"22","key":"10.1016\/j.survophthal.2021.05.007_bib0415","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.3748\/wjg.v13.i22.3137","article-title":"Intraocular complications of IFN-alpha and ribavirin therapy in patients with chronic viral hepatitis C","volume":"13","author":"Sene","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0416","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/OGX.0b013e31816400d7","article-title":"Selective estrogen receptor modulators: An update on recent clinical findings","volume":"63","author":"Shelly","year":"2008","journal-title":"Obstet Gynecol Surv"},{"issue":"11","key":"10.1016\/j.survophthal.2021.05.007_bib0417","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/BF00171387","article-title":"Transforming growth factor-beta regulates human retinal pigment epithelial cell phagocytosis by influencing a protein kinase C-dependent pathway","volume":"232","author":"Sheu","year":"1994","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0418","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3928\/23258160-20151214-12","article-title":"Long-term evaluation of MEK inhibitor retinal toxicity with multimodal imaging","volume":"47","author":"Sheyman","year":"2016","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"26","key":"10.1016\/j.survophthal.2021.05.007_bib0419","doi-asserted-by":"crossref","first-page":"e11229","DOI":"10.1097\/MD.0000000000011229","article-title":"Impaired retinal pigment epithelium in paclitaxel-induced macular edema: A case report","volume":"97","author":"Shih","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"5429","key":"10.1016\/j.survophthal.2021.05.007_bib0420","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/246151a0","article-title":"Cytosine arabinoside and rosette formation in mouse retina","volume":"246","author":"Shimada","year":"1973","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0421","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3171\/jns.1990.72.2.0285","article-title":"Optic nerve degeneration caused by supraophthalmic carotid artery infusion with cisplatin and ACNU. Case report","volume":"72","author":"Shimamura","year":"1990","journal-title":"J Neurosurg"},{"issue":"11","key":"10.1016\/j.survophthal.2021.05.007_bib0422","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1001\/archopht.1982.01030040746007","article-title":"Ocular toxicity associated with high-dose carmustine","volume":"100","author":"Shingleton","year":"1982","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0423","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1542\/peds.70.2.288","article-title":"Optic atrophy induced by vincristine","volume":"70","author":"Shurin","year":"1982","journal-title":"Pediatrics"},{"issue":"18","key":"10.1016\/j.survophthal.2021.05.007_bib0424","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1001\/jama.1977.03280190053032","article-title":"Sicca syndrome in a patient with toxic reaction to busulfan","volume":"238","author":"Sidi","year":"1977","journal-title":"Jama"},{"issue":"11","key":"10.1016\/j.survophthal.2021.05.007_bib0425","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1001\/archopht.126.11.1605","article-title":"Cystoid macular edema secondary to albumin-bound paclitaxel therapy","volume":"126","author":"Smith","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0426","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/978-3-540-69297-3_8","article-title":"Anti-angiogenic properties of chemopreventive drugs: Fenretinide as a prototype","volume":"181","author":"Sogno","year":"2009","journal-title":"Recent Results Cancer Res"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0427","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1471-4159.2005.03510.x","article-title":"Fibroblast growth factor 2 applied to the optic nerve after axotomy up-regulates BDNF and TrkB in ganglion cells by activating the ERK and PKA signaling pathways","volume":"96","author":"Soto","year":"2006","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0428","first-page":"69","article-title":"[Evaluation of risk factors of interferon-associated retinopathy in patients with type C chronic active hepatitis]","volume":"100","author":"Soushi","year":"1996","journal-title":"Nippon Ganka Gakkai Zasshi"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0429","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1600-0609.1984.tb02167.x","article-title":"Effectiveness of pentostatin (2\u2032-deoxycoformycin) in refractory lymphoid neoplasms","volume":"32","author":"Spiers","year":"1984","journal-title":"Scand J Haematol"},{"issue":"11","key":"10.1016\/j.survophthal.2021.05.007_bib0430","first-page":"5953","article-title":"Fludarabine phosphate (NSC 312878) infusions for the treatment of acute leukemia: Phase I and neuropathological study","volume":"46","author":"Spriggs","year":"1986","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0431","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4103\/0973-1482.73332","article-title":"Crystalline maculopathy: A rare complication of tamoxifen therapy","volume":"6","author":"Srikantia","year":"2010","journal-title":"J Cancer Res Ther"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0432","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/0002-9394(74)90231-1","article-title":"Microsphere occlusion of the choriocapillaris in rhesus monkeys","volume":"78","author":"Stern","year":"1974","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0433","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0002-9394(83)90453-1","article-title":"Ocular toxicity of fluorouracil after vitrectomy","volume":"96","author":"Stern","year":"1983","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.007_bib0434","first-page":"2059","article-title":"A phase I study of intracarotid artery infusion of cis-Diamminedichloroplatinum(II) in patients with recurrent malignant intracerebral tumors","volume":"42","author":"Stewart","year":"1982","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0435","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/annonc\/mdw100","article-title":"Ocular toxicities of MEK inhibitors and other targeted therapies","volume":"27","author":"Stjepanovic","year":"2016","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.survophthal.2021.05.007_bib0436","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1111\/j.1572-0241.1998.00701.x","article-title":"Retinal complications and plasma C5a levels during interferon alpha therapy for chronic hepatitis C","volume":"93","author":"Sugano","year":"1998","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.survophthal.2021.05.007_bib0437","first-page":"2054","article-title":"Retinal complications with elevated circulating plasma C5a associated with interferon-alpha therapy for chronic active hepatitis C","volume":"89","author":"Sugano","year":"1994","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0438","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.ejca.2012.11.019","article-title":"Resistance to BRAF-targeted therapy in melanoma","volume":"49","author":"Sullivan","year":"2013","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0439","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1046\/j.1365-2893.2003.00456.x","article-title":"Vogt-Koyanagi-Harada disease associated with interferon alpha-2b\/ribavirin combination therapy","volume":"10","author":"Sylvestre","year":"2003","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0440","doi-asserted-by":"crossref","first-page":"S163","DOI":"10.1016\/S0753-3322(05)80025-3","article-title":"Recombinant interferon alpha treatment decreases heart rate variability indices and impairs exercise tolerance in patients with chronic hepatitis","volume":"59","author":"Takase","year":"2005","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0441","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/clc.4960240406","article-title":"Endothelial dysfunction and decreased exercise tolerance in interferon-alpha therapy in chronic hepatitis C: Relation between exercise hyperemia and endothelial function","volume":"24","author":"Takase","year":"2001","journal-title":"Clin Cardiol"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0442","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1167\/iovs.02-1030","article-title":"Immune responses to retinal self-antigens in CD25(+)CD4(+) regulatory T-cell-depleted mice","volume":"45","author":"Takeuchi","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0443","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/(SICI)1096-911X(199809)31:3<177::AID-MPO11>3.0.CO;2-J","article-title":"Ocular toxicity secondary to paclitaxel in two lung cancer patients","volume":"31","author":"Tan","year":"1998","journal-title":"Med Pediatr Oncol"},{"issue":"Pt 3","key":"10.1016\/j.survophthal.2021.05.007_bib0444","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/eye.1997.64","article-title":"Retinal changes associated with tamoxifen treatment for breast cancer","volume":"11","author":"Tang","year":"1997","journal-title":"Eye (Lond)"},{"issue":"10","key":"10.1016\/j.survophthal.2021.05.007_bib0445","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1093\/jn\/134.10.2573","article-title":"The night vision threshold test is a better predictor of low serum vitamin A concentration than self-reported night blindness in pregnant urban Nepalese women","volume":"134","author":"Taren","year":"2004","journal-title":"J Nutr"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0446","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ajoc.2016.04.004","article-title":"A case of recurrent bilateral uveitis independently associated with dabrafenib and pembrolizumab therapy","volume":"2","author":"Taylor","year":"2016","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0447","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/00006324-200304000-00004","article-title":"Cystic maculopathy with normal capillary permeability secondary to docetaxel","volume":"80","author":"Teitelbaum","year":"2003","journal-title":"Optom Vis Sci"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0448","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/08820530701457373","article-title":"Cystoid macular edema with docetaxel chemotherapy and the fluid retention syndrome","volume":"22","author":"Telander","year":"2007","journal-title":"Semin Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0449","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/aos.12092","article-title":"Multimodal imaging of the macula in hereditary and acquired lack of macular pigment","volume":"92","author":"Theelen","year":"2014","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.007_bib0450","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0002-9394(14)71451-5","article-title":"Interferon alfa-2a in the treatment of subfoveal choroidal neovascularization","volume":"115","author":"Thomas","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0451","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2741\/1848","article-title":"Signal transduction in CD4+CD25+ regulatory T cells: CD25 and IL-2","volume":"11","author":"Thornton","year":"2006","journal-title":"Front Biosci"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.007_bib0452","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.oret.2017.01.001","article-title":"OCT angiography findings in tamoxifen maculopathy","volume":"1","author":"Todorich","year":"2017","journal-title":"Ophthalmol Retina"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.007_bib0453","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0049-3848(00)00294-2","article-title":"Cisplatin triggers platelet activation","volume":"99","author":"Togna","year":"2000","journal-title":"Thromb Res"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0454","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1600-0773.1998.tb01477.x","article-title":"Effects of tamoxifen, toremifene and chloroquine on the lysosomal enzymes in cultured retinal pigment epithelial cells","volume":"83","author":"Toimela","year":"1998","journal-title":"Pharmacol Toxicol"},{"issue":"7","key":"10.1016\/j.survophthal.2021.05.007_bib0455","first-page":"1077","article-title":"Interferon-associated retinopathy and cystoid macular edema","volume":"119","author":"Tokai","year":"2001","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.007_bib0456","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1089\/jop.2011.0218","article-title":"Diosmin protects rat retina from ischemia\/reperfusion injury","volume":"28","author":"Tong","year":"2012","journal-title":"J Ocul Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0457","first-page":"507","article-title":"Factors affecting plasma retinol decline during long-term administration of the synthetic retinoid fenretinide in breast cancer patients","volume":"3","author":"Torrisi","year":"1994","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0458","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2147\/CMAR.S49494","article-title":"Treating advanced melanoma: Current insights and opportunities","volume":"6","author":"Tronnier","year":"2014","journal-title":"Cancer Manag Res"},{"issue":"12","key":"10.1016\/j.survophthal.2021.05.007_bib0459","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jamaophthalmol.2017.4872","article-title":"Combination ipilimumab and nivolumab for metastatic melanoma associated with ciliochoroidal effusion and exudative retinal detachment","volume":"135","author":"Tsui","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0460","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/bjo.87.2.247","article-title":"Severe interferon associated retinopathy","volume":"87","author":"Tu","year":"2003","journal-title":"Br J Ophthalmol"},{"issue":"4440","key":"10.1016\/j.survophthal.2021.05.007_bib0461","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1126\/science.7361117","article-title":"Magnesium deficiency produces spasms of coronary arteries: Relationship to etiology of sudden death ischemic heart disease","volume":"208","author":"Turlapaty","year":"1980","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.007_bib0462","first-page":"551","article-title":"Comparative teratogenicity of nine retinoids in the rat","volume":"73","author":"Turton","year":"1992","journal-title":"Int J Exp Pathol"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0463","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12886-018-0861-8","article-title":"New features in MEK retinopathy","volume":"18","author":"Tyagi","year":"2018","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0464","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejca.2016.06.018","article-title":"MEK inhibitor-associated retinopathy (MEKAR) in metastatic melanoma: Long-term ophthalmic effects","volume":"65","author":"Urner-Bloch","year":"2016","journal-title":"Eur J Cancer"},{"issue":"7","key":"10.1016\/j.survophthal.2021.05.007_bib0465","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/annonc\/mdu169","article-title":"Transient MEK inhibitor-associated retinopathy in metastatic melanoma","volume":"25","author":"Urner-Bloch","year":"2014","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0466","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ctrv.2013.01.003","article-title":"Effect of inhibition of the FGFR-MAPK signaling pathway on the development of ocular toxicities","volume":"39","author":"van der Noll","year":"2013","journal-title":"Cancer Treat Rev"},{"issue":"9","key":"10.1016\/j.survophthal.2021.05.007_bib0467","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.ophtha.2015.05.027","article-title":"Serous retinopathy associated with mitogen-activated protein kinase kinase inhibition (binimetinib) for metastatic cutaneous and uveal melanoma","volume":"122","author":"van Dijk","year":"2015","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.007_bib0468","doi-asserted-by":"crossref","first-page":"e12863","DOI":"10.1111\/sji.12863","article-title":"Interferon \u03b1 in cancer immunoediting: From elimination to escape","volume":"91","author":"Vidal","year":"2020","journal-title":"Scand J Immunol"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0469","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.immuni.2006.08.008","article-title":"Fifty years of interferon research: Aiming at a moving target","volume":"25","author":"Vilcek","year":"2006","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0470","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1755-3768.1983.tb01393.x","article-title":"Retinopathy caused by treatment with tamoxifen in low dosage","volume":"61","author":"Vinding","year":"1983","journal-title":"Acta Ophthalmol (Copenh)"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.007_bib0471","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF00686148","article-title":"Phase I study using desferrioxamine and iron sorbitol citrate in an attempt to modulate the iron status of tumor cells to enhance doxorubicin activity","volume":"31","author":"Voest","year":"1993","journal-title":"Cancer Chemother Pharmacol"},{"issue":"23","key":"10.1016\/j.survophthal.2021.05.007_bib0472","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","article-title":"Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial","volume":"295","author":"Vogel","year":"2006","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0473","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1158\/1940-6207.CAPR-10-0076","article-title":"Update of the national surgical adjuvant breast and bowel project study of tamoxifen and raloxifene (STAR) P-2 trial: Preventing breast cancer","volume":"3","author":"Vogel","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"issue":"12","key":"10.1016\/j.survophthal.2021.05.007_bib0474","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1002\/1097-0142(19851215)56:12<2765::AID-CNCR2820561208>3.0.CO;2-2","article-title":"Hypomagnesemia, renal dysfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin","volume":"56","author":"Vogelzang","year":"1985","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0475","first-page":"405","article-title":"Ophthalmological and other toxicities related to cytosine arabinoside and total body irradiation as preparative regimen for bone marrow transplantation","volume":"6","author":"Vogler","year":"1990","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0476","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125631","article-title":"A comparison of some organizational characteristics of the mouse central retina and the human macula","volume":"10","author":"Volland","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0477","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/bcp.13078","article-title":"Pimasertib, a selective oral MEK1\/2 inhibitor: Absolute bioavailability, mass balance, elimination route, and metabolite profile in cancer patients","volume":"82","author":"von Richter","year":"2016","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.007_bib0478","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1006\/exer.2001.1078","article-title":"Neurotrophic signaling in normal and degenerating rodent retinas","volume":"73","author":"Wahlin","year":"2001","journal-title":"Exp Eye Res"},{"issue":"23","key":"10.1016\/j.survophthal.2021.05.007_bib0479","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1056\/NEJM198012043032303","article-title":"Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery","volume":"303","author":"Walker","year":"1980","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.007_bib0480","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1006\/exer.2000.0984","article-title":"Cellular and subcellular patterns of expression of bFGF and CNTF in the normal and light stressed adult rat retina","volume":"72","author":"Walsh","year":"2001","journal-title":"Exp Eye Res"},{"issue":"11","key":"10.1016\/j.survophthal.2021.05.007_bib0481","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/archneur.1982.00510230045013","article-title":"Neurotoxic effects of cisplatin therapy","volume":"39","author":"Walsh","year":"1982","journal-title":"Arch Neurol"},{"issue":"8","key":"10.1016\/j.survophthal.2021.05.007_bib0482","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.bbamcr.2006.11.009","article-title":"Clinical experience of MEK inhibitors in cancer therapy","volume":"1773","author":"Wang","year":"2007","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0483","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.preteyeres.2010.11.001","article-title":"The cone-specific visual cycle","volume":"30","author":"Wang","year":"2011","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0484","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0002-9394(00)00522-5","article-title":"Bilateral blindness and lumbosacral myelopathy associated with high-dose carmustine and cisplatin therapy","volume":"130","author":"Wang","year":"2000","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2021.05.007_bib0485","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1021\/ja00738a045","article-title":"Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia","volume":"93","author":"Wani","year":"1971","journal-title":"J Am Chem Soc"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0486","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1200\/JCO.1986.4.1.74","article-title":"Phase I and II study of fludarabine phosphate in leukemia: Therapeutic efficacy with delayed central nervous system toxicity","volume":"4","author":"Warrell","year":"1986","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0487","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3109\/15569527.2011.641197","article-title":"Branch retinal artery occlusion and central retinal vein occlusion associated with pegylated interferon plus ribavirin combination therapy for chronic hepatitis C","volume":"31","author":"Watanabe","year":"2012","journal-title":"Cutan Ocul Toxicol"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0488","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10633-009-9203-8","article-title":"Retinal function in patients treated with tamoxifen","volume":"120","author":"Watanabe","year":"2010","journal-title":"Doc Ophthalmol"},{"issue":"12","key":"10.1016\/j.survophthal.2021.05.007_bib0489","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00417-002-0573-9","article-title":"Severe ocular and orbital toxicity after intracarotid injection of carboplatin for recurrent glioblastomas","volume":"240","author":"Watanabe","year":"2002","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"36","key":"10.1016\/j.survophthal.2021.05.007_bib0490","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1200\/JCO.2008.16.1927","article-title":"Phase I\/II study of ipilimumab for patients with metastatic melanoma","volume":"26","author":"Weber","year":"2008","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.survophthal.2021.05.007_bib0491","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/jamaophthalmol.2016.0090","article-title":"Subretinal fluid associated with MEK inhibitor use in the treatment of systemic cancer","volume":"134","author":"Weber","year":"2016","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0492","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/pbc.20638","article-title":"Vincristine sulfate as a possible cause of optic neuropathy","volume":"48","author":"Weisfeld-Adams","year":"2007","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0493","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0305-7372(82)80043-1","article-title":"The nitrosoureas: Carmustine (BCNU) and lomustine (CCNU)","volume":"9","author":"Weiss","year":"1982","journal-title":"Cancer Treat Rev"},{"issue":"6","key":"10.1016\/j.survophthal.2021.05.007_bib0494","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/archopht.1986.01050180065031","article-title":"Abnormal retinal function associated with isotretinoin therapy for acne","volume":"104","author":"Weleber","year":"1986","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2021.05.007_bib0495","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0092-8674(00)80602-9","article-title":"Insights into the function of Rim protein in photoreceptors and etiology of Stargardt's disease from the phenotype in abcr knockout mice","volume":"98","author":"Weng","year":"1999","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.survophthal.2021.05.007_bib0496","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1200\/JCO.1985.3.12.1683","article-title":"Retinal toxicity after high-dose cisplatin therapy","volume":"3","author":"Wilding","year":"1985","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.007_bib0497","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1158\/1078-0432.CCR-11-2479","article-title":"Selective BRAF inhibitors induce marked T-cell infiltration into human metastatic melanoma","volume":"18","author":"Wilmott","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0498","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s40425-016-0170-9","article-title":"Acute visual loss after ipilimumab treatment for metastatic melanoma","volume":"4","author":"Wilson","year":"2016","journal-title":"J Immunother Cancer"},{"issue":"11","key":"10.1016\/j.survophthal.2021.05.007_bib0499","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1001\/archophthalmol.2011.361","article-title":"Superselective intraophthalmic artery chemotherapy: What we do not know","volume":"129","author":"Wilson","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0500","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00006982-199414030-00011","article-title":"Occlusive microvascular retinopathy with optic disc and retinal neovascularization in acute lymphocytic leukemia","volume":"14","author":"Wiznia","year":"1994","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0501","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1634\/theoncologist.13-S4-2","article-title":"The mechanism of anti-CTLA-4 activity and the negative regulation of T-cell activation","volume":"13","author":"Wolchok","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0502","first-page":"1","article-title":"Intravitreal steroid treatment for uveitis associated with dabrafenib and trametinib for metastatic cutaneous melanoma","author":"Woltsche","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"issue":"3","key":"10.1016\/j.survophthal.2021.05.007_bib0503","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1586\/17469899.2014.921119","article-title":"Management of conjunctival malignant melanoma: A review and update","volume":"9","author":"Wong","year":"2014","journal-title":"Expert Rev Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2021.05.007_bib0504","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/ICB.0b013e31824f7130","article-title":"Bilateral drug (ipilimumab)-induced vitritis, choroiditis, and serous retinal detachments suggestive of vogt-koyanagi-harada syndrome","volume":"6","author":"Wong","year":"2012","journal-title":"Retin Cases Brief Rep"},{"issue":"11","key":"10.1016\/j.survophthal.2021.05.007_bib0505","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s40265-013-0096-1","article-title":"Trametinib: First global approval","volume":"73","author":"Wright","year":"2013","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.survophthal.2021.05.007_bib0506","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/WNO.0000000000000217","article-title":"Ipilimumab-associated bilateral optic neuropathy","volume":"35","author":"Yeh","year":"2015","journal-title":"J Neuroophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2021.05.007_bib0507","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ophtha.2008.12.004","article-title":"Ocular and systemic autoimmunity after successful tumor-infiltrating lymphocyte immunotherapy for recurrent, metastatic melanoma","volume":"116","author":"Yeh","year":"2009","journal-title":"Ophthalmology"},{"issue":"9-10","key":"10.1016\/j.survophthal.2021.05.007_bib0508","first-page":"1539","article-title":"cis-Dichlorodiammineplatinum(II) for the treatment of advanced ovarian cancer","volume":"63","author":"Young","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0509","first-page":"30","article-title":"What can we learn about age-related macular degeneration from other retinal diseases?","volume":"5","author":"Zack","year":"1999","journal-title":"Mol Vis"},{"issue":"30","key":"10.1016\/j.survophthal.2021.05.007_bib0510","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.3748\/wjg.v12.i30.4908","article-title":"Retinal vein thrombosis associated with pegylated-interferon and ribavirin combination therapy for chronic hepatitis C","volume":"12","author":"Zandieh","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0511","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0083-6729(04)69010-8","article-title":"Plasma retinol-binding protein: Structure and interactions with retinol, retinoids, and transthyretin","volume":"69","author":"Zanotti","year":"2004","journal-title":"Vitam Horm"},{"issue":"7","key":"10.1016\/j.survophthal.2021.05.007_bib0512","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrclinonc.2014.83","article-title":"The clinical development of MEK inhibitors","volume":"11","author":"Zhao","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0513","doi-asserted-by":"crossref","DOI":"10.3410\/B2-3","article-title":"Ocular immune privilege","volume":"2","author":"Zhou","year":"2010","journal-title":"F1000 Biol Rep"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0514","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejca.2016.02.024","article-title":"Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy","volume":"60","author":"Zimmer","year":"2016","journal-title":"Eur J Cancer"},{"issue":"7","key":"10.1016\/j.survophthal.2021.05.007_bib0515","first-page":"475","article-title":"Side effects of systemic oncological therapies in dermatology","volume":"10","author":"Zimmer","year":"2012","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0014a","unstructured":"http:\/\/www.nih.gov\/news-events\/news-releases\/ cancer-costs-projected-reach-least-158-billion-2020"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0014b","unstructured":"www.cancerresearchuk.org"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0014c","unstructured":"https:\/\/chemoth.com\/economics"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0014d","unstructured":"SEER, Surveillance, Epidemiology and End Results Program. SEER Cancer Statistics Factsheets: Melanoma of the Skin. National Cancer Institute, Bethesda, MD. Available at http:\/\/seer.cancer.gov\/statfacts\/html\/melan.html."},{"key":"10.1016\/j.survophthal.2021.05.007_bib0014e","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02096471"},{"key":"10.1016\/j.survophthal.2021.05.007_bib0014f","unstructured":"Cancer Institute N. Common Terminology Criteria for Adverse Events (CTCAE) Common Terminology Criteria for Adverse Events (CTCAE) v5.0. 2017. Available at: https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_5x7.pdf."},{"key":"10.1016\/j.survophthal.2021.05.007_bib0014g","unstructured":"Bedford Laboratories. Pentostatin for injection prescribing information. Bedford, OH: Bedford Laboratories; 2006."}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625721001296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625721001296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:56:03Z","timestamp":1758542163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625721001296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":522,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0039625721001296"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2021.05.007","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retinal toxicities of systemic anticancer drugs","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2021.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}